好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2024 Annual Meeting | P10 - Poster Session 10

Wednesday 04/17/24
11:45 AM - 12:45 PM MDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Scientific Poster Session
General Neurology, Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, 好色先生, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), Global Health and Neuroepidemiology, Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuro-ophthalmology/Neuro-otology, Neurocritical Care, Sleep, Neuromuscular and Clinical Neurophysiology (EMG)
View the latest research on a variety of topics. Posters are available in-person or online.
0.00 CME credit
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator
Interactive
Event Timeline
11:45 AM - 12:45 PM MDT Abstract 9-001 - Effectiveness and Optimization of Low-sodium Oxybate in Participants with Narcolepsy Switching from Sodium Oxybate: Final Data from the Substitution of Equal Grams of Uninterrupted Xyrem to Xywav (SEGUE) Study
Douglas S. Fuller
11:45 AM - 12:45 PM MDT Abstract 9-002 - Samelisant (SUVN-G3031) - Topline Results from the Phase-2 Proof-of-Concept Double-blind, Placebo-controlled Study in Patients with Narcolepsy
Ramakrishna Nirogi, PhD
11:45 AM - 12:45 PM MDT Abstract 9-003 - Efficacy of Low-sodium Oxybate by Baseline Sleep Inertia in a Phase 3 Clinical Study in Participants with Idiopathic Hypersomnia
Marisa Whalen
11:45 AM - 12:45 PM MDT Abstract 9-004 - Global Incidence and Clinical Characteristics of Sleeping Paralysis: A Systematic Review and Meta-analysis
Ahmed Negida, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 9-005 - Minimal Clinically Important Difference for the Visual Analog Scale for Sleep Inertia Using Data from a Phase 3 Trial of Low-sodium Oxybate for Idiopathic Hypersomnia
Logan D. Schneider, MD
11:45 AM - 12:45 PM MDT Abstract 9-006 - Effects of Oxybate on Sleep, Sleep Architecture, and Disrupted Nighttime Sleep
Jed Black, MD
11:45 AM - 12:45 PM MDT Abstract 9-007 - Actigraphic and Genetic Characterization of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Phenotypes in the UK Biobank
Patrick Z. Liu, PhD
11:45 AM - 12:45 PM MDT Abstract 9-008 - Consistent Efficacy of Once-nightly Sodium Oxybate Regardless of Patient Demographic and Baseline Disease Characteristics
Michael J. Thorpy, MD
11:45 AM - 12:45 PM MDT Abstract 9-009 - Solriamfetol for Excessive Sleepiness in Narcolepsy and Obstructive Sleep Apnea: Effect Sizes and Numbers Needed to Treat or Harm
Samantha Floam, DMD
11:45 AM - 12:45 PM MDT Abstract 9-010 - The Relationship Between Disordered Sleep and Pain Perception in Patients with Peripheral Neuropathy
Julia Greenberg, MD
11:45 AM - 12:45 PM MDT Abstract 9-011 - 31-year-old Male with Patau Syndrome: A Rare Case of Long-term Survival
Deap S. Bhandal
11:45 AM - 12:45 PM MDT Abstract 9-012 - Advanced Description of a Large Cohort of Patients with Creutzfeldt-Jakob Disease
Ada Breitenbucher, MD
11:45 AM - 12:45 PM MDT Abstract 9-013 - Factors Influencing Time to Diagnosis of Creutzfeldt Jakob Disease
Kanchan Kumari, MBBS
11:45 AM - 12:45 PM MDT Abstract 9-014 - Application of a Standardized and Reproducible Definition of Rapidly Progressive Dementia
Nihal Satyadev, MD, MPH
11:45 AM - 12:45 PM MDT Abstract 9-015 - Ancillary Service Utilization Patterns in Functional Neurological Disorder Patients: A Retrospective Cohort Study
Marlie Winslow, MD
11:45 AM - 12:45 PM MDT Abstract 9-016 - An Investigation of Maladaptive Health Behavior Engagement and Neurobehavioral and Neurocognitive Outcomes in Former Elite American Football Players
Tahlia Bragg
11:45 AM - 12:45 PM MDT Abstract 15-001 - A Brain Care Score for Risk of Late-life Depression: Data from the UK Biobank Cohort
Sanjula D. Singh, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 15-002 - A Brain Care Score for Dementia and Stroke: Data from the UK Biobank Cohort
Sanjula D. Singh, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 15-003 - Neurological Manifestations of Long COVID: A Systematic Review
Nithin C. Kurra, MBBS, MPH
11:45 AM - 12:45 PM MDT Abstract 15-004 - Long-term Effect of COVID on the Brain: Systemic Review and Meta-analysis
Ahmed Negida, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 3-001 - Safety and Tolerability of Ecopipam in Tourette Syndrome with Psychiatric Comorbidities
Donald Gilbert, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 3-002 - Evaluating the Need for Intervention in Tourette Syndrome
Sarah G. Trulove, MBA
11:45 AM - 12:45 PM MDT Abstract 3-003 - Obsessive-compulsive Themes in Children with Tic Disorders Differ from Those in the General Pediatric OCD Population
Irene Malaty, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 3-004 - Quality of Life in Males and Females with Tic Disorders
Natalia Szejko, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 3-005 - Pharmacodynamics of Eladocagene Exuparvovec and Safety of the SmartFlow Magnetic Resonance-compatible Ventricular Cannula for Administering Eladocagene Exuparvovec in Pediatric Participants
PHILLIP L. PEARL, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 3-008 - Expanding the Phenotype of BCL11B-related Disorders: A Case Series of Primary Movement Disorders with Literature Review
Ginny Lane
11:45 AM - 12:45 PM MDT Abstract 3-010 - Effects of Ecopipam on Growth and Development in Juvenile Rats
Stephen Wanaski, PhD
11:45 AM - 12:45 PM MDT Abstract 3-011 - Incidence and Characterization of Delayed-onset Movement Disorders Following Thrombolysis or Thrombectomy for Acute Ischemic Stroke: A Retrospective Cohort Study
Aya N. Shnawa, MD
11:45 AM - 12:45 PM MDT Abstract 3-012 - Shaping the Future of Neurological Wilson’s Disease Assessment and Monitoring with Novel Digital Biomarkers
Clarissa Gorin, Other
11:45 AM - 12:45 PM MDT Abstract 3-014 - The Use of Electrophysiology for Movement Disorders: Experience from a Single Academic Center’s Clinical Practice
Katherine Longardner, MD
11:45 AM - 12:45 PM MDT Abstract 3-015 - Rescue Surgery in Elderly Hemifacial Spasm Patients Refractory to Botulinum Toxin
Margaret Tugend
11:45 AM - 12:45 PM MDT Abstract 3-016 - Motivation States for Bodily Movement in Hyperkinetic Movement Disorders: A Scoping Review
Danielle A. Reynolds, MD
11:45 AM - 12:45 PM MDT Abstract 3-017 - Study of Diabetic Striatopathy in Rural Type-2 Diabetic Patients
Mohamed Ibrahim A. Aleem, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 3-018 - A Study on Clinical Profile of Patients Presenting as an Emergency with Movement Disorders to a Tertiary Care Center–A Preliminary Report
Chintha V. Sriram, MD, MBBS
11:45 AM - 12:45 PM MDT Abstract 3-019 - Manganese Neurotoxicity in the Setting of Alcoholic Cirrhosis
Anooshah E. Ata, MD
11:45 AM - 12:45 PM MDT Abstract 12-001 - A Case of Paraneoplastic Trigeminal Neuropathy in the Setting of Renal Cell Carcinoma
Eric Dunn, DO
11:45 AM - 12:45 PM MDT Abstract 12-002 - Rare Case of Complete Facial Diplegia After Botulinum Toxin Injections for Chronic Migraine
Ashhar Ali, DO, FAAN
11:45 AM - 12:45 PM MDT Abstract 12-003 - Post-COVID Hemicrania Continua: A Case Report
Sara Zeccardi, NP
11:45 AM - 12:45 PM MDT Abstract 12-004 - What a Rare Case of a Cerebrospinal Fluid Leak in a Transgender Male Can Teach Us About Idiopathic Intracranial Hypertension
Isaac Smith, DO, MS
11:45 AM - 12:45 PM MDT Abstract 12-005 - SUNCT-like Symptoms Within an Opalski Syndrome: An Atypical Neurological Conundrum
Jose F. Ortega Tola, MD
11:45 AM - 12:45 PM MDT Abstract 12-006 - A Case of Refractory Chronic Migraines and Cluster Headaches Responsive to Peripheral Nerve Stimulator
Co D. Duong, MD
11:45 AM - 12:45 PM MDT Abstract 12-007 - Correlation of Headache Frequency and Intensity with the Risk of Obstructive Sleep Apnea in Patients with Idiopathic Intracranial Hypertension
Cristina A. Cruz, MD
11:45 AM - 12:45 PM MDT Abstract 12-008 - Occipital Nerve Block Leading to the Discovery of Carcinosarcoma
Ashhar Ali, DO, FAAN
11:45 AM - 12:45 PM MDT Abstract 12-010 - Blinded Epidural Blood Patch for Treating a Man with Antiphospholipid Syndrome and Autoimmune Thrombocytopenia Presenting with Spontaneous Intracranial Hypotension
Gabriela Petersen, MD
11:45 AM - 12:45 PM MDT Abstract 6-001 - Efficacy of Frexalimab on Physical and Psychological Impacts and Fatigue in Relapsing Multiple Sclerosis: Findings from MSIS-29v2 and PROMIS-Fatigue-MS-8a Assessments in a Phase 2 Trial
Patrick Vermersch
11:45 AM - 12:45 PM MDT Abstract 6-002 - Implementation of a Safety Program Initiative for Monitoring Infusion Disease Modifying Therapies for Multiple Sclerosis
Shuvro Roy, MD
11:45 AM - 12:45 PM MDT Abstract 6-003 - OCARINA I, Phase Ib Study: Dose Selection of Subcutaneous Ocrelizumab in Patients with Multiple Sclerosis
Scott D. Newsome, DO, FAAN
11:45 AM - 12:45 PM MDT Abstract 6-004 - Health Economic Impact and Highlighted Clinical/Safety Outcomes in 300 Relapsing Multiple Sclerosis Patients Treated with Alemtuzumab in a Single MS Center
Ryan Shannon, NP
11:45 AM - 12:45 PM MDT Abstract 6-005 - Reduced Risk of Progressive Multifocal Leukoencephalopathy (PML) with Natalizumab Extended Interval Dosing (EID) Compared with Every-4-week (Q4W) Dosing: Updated Analysis of the TOUCH® Prescribing Program Database
Lana Zhovtis Ryerson, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 6-006 - OLIKOS Study: 6-month Interim Efficacy and Safety in Patients with Relapsing Multiple Sclerosis Who Switched to Subcutaneous Ofatumumab from Intravenous Anti-CD20 Therapies
Enrique Alvarez, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 6-007 - Low Disease Activity Over 4 Years of Ocrelizumab Therapy in Treatment-naive Patients with High-activity, Early-stage Relapsing-remitting Multiple Sclerosis in the ENSEMBLE Study
Hans-Peter Hartung, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 6-008 - Prospective Longitudinal Study of Cladribine Tablets (CLADB Study) Demonstrates Sustained Reduction in Kappa Free Light Chains in Relapsing Multiple Sclerosis (RRMS) at 96 Weeks
Sharmilee Gnanapavan, MB
11:45 AM - 12:45 PM MDT Abstract 6-009 - Ocrelizumab-induced Typhlitis (Neutropenic Enterocolitis)
Dania Mallick, MBBS
11:45 AM - 12:45 PM MDT Abstract 6-010 - Late-onset Severe Neutropenia in a Patient with Relapsing Remitting Multiple Sclerosis Treated with Ocrelizumab
Catherine Tauro, DO
11:45 AM - 12:45 PM MDT Abstract 6-011 - A Two-part, Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Fenebrutinib (Part A) and the Effect of Fenebrutinib on the QT/QTc Interval in Healthy Participants (Part B)
Maresa Caunt
11:45 AM - 12:45 PM MDT Abstract 6-012 - Safety Patterns over Time with Ozanimod During an Open-label Extension Trial in Patients with Relapsing Multiple Sclerosis
Krzysztof W. Selmaj
11:45 AM - 12:45 PM MDT Abstract 6-013 - Absolute Lymphocyte Count Around Infections During Phase 3 and Open-label Extension Trials of Ozanimod in Participants with Relapsing Multiple Sclerosis
Hans-Peter Hartung, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 6-014 - Safety and Efficacy of Ozanimod in Patients with Early Relapsing Multiple Sclerosis: 1-year Analysis of the ENLIGHTEN Study
Ahmed Z. Obeidat, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 6-015 - Treatment Persistence of Cladribine Tablets Versus Other Oral Disease-modifying Treatments for Multiple Sclerosis: Results from Danish, Norwegian, and Swedish Registries
Gerard Harty
11:45 AM - 12:45 PM MDT Abstract 6-016 - Comparing Longitudinal Changes in Immunoglobulin G and M Profiles in MS Patients Undergoing B-cell Depleting Therapy: A Retrospective Analysis
Himali Bergeron-Vitez
11:45 AM - 12:45 PM MDT Abstract 6-017 - Comparison of Multiple Sclerosis Patients With or Without Rebound Activity After Fingolimod Cessation: Five-Year Clinical Outcomes
Bade Gulec
11:45 AM - 12:45 PM MDT Abstract 6-018 - The Bruton’s Tyrosine Kinase Inhibitor Remibrutinib Exhibits No Impact on Serum Immunoglobulin Levels: Insights from Chronic Spontaneous Urticaria
Robert A. Bermel, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 7-001 - CEINN and REINN - Lessons from Pilot Pathways Programs for Clinical and Research Experiences in Neurology and Neurosurgery
Neishay Ayub, MD
11:45 AM - 12:45 PM MDT Abstract 7-002 - Exploring Brain Health with High School Students: A SIGN Event
Abigail E. Connor
11:45 AM - 12:45 PM MDT Abstract 7-003 - Combatting “Neurophobia”: A Proposed Preliminary 好色先生al Model to Promote “Neurophilia”
Richard I. Suarez, MD
11:45 AM - 12:45 PM MDT Abstract 7-005 - Development of a Clerkship Reflection Session to Address Medical Students’ Misconceptions of the Field of Neurology
Nicholas Fioravante, MD
11:45 AM - 12:45 PM MDT Abstract 7-006 - Impact of Mandatory Neurology Clerkship Experience for Undergraduate Medical Students on Neurology Residency Applications
Patrick Callaghan, MD
11:45 AM - 12:45 PM MDT Abstract 7-007 - Enhancing Undergraduate Medical Student Neurology Exposure via the Texas A&M College of Medicine's Student Interest Group in Neurology (SIGN) Results in Higher Neurology Residency Matches
Maya M. Ramy, MD
11:45 AM - 12:45 PM MDT Abstract 7-008 - Neurophobia Experienced by Medical Students in India
Hayes Fountain, MEd
11:45 AM - 12:45 PM MDT Abstract 1-001 - Beyond the Hospital Walls: Unpacking the Complexities of Acute ASM Initiation and Patient Follow-up
Lorena M. Figueredo Rivas, MD
11:45 AM - 12:45 PM MDT Abstract 1-002 - Complex Enough?: Evaluating Reliability in Rating Medical Complexity of a Vulnerable Group of Patients with Epilepsy
Jonathan P. Williams, MD, MSCR
11:45 AM - 12:45 PM MDT Abstract 1-003 - Unleashing the Potential of Telemedicine in Epilepsy: Effectiveness and Patient Preferences
Rani Priyanka Vasireddy, MBBS
11:45 AM - 12:45 PM MDT Abstract 1-004 - Housing Status and Healthcare Utilization in People Presenting with Seizures
Nicole Rosendale, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 1-005 - Optimal Care Access Disparities in Adult Non-English-speaking Patients with Drug-resistant Epilepsy
Cindy McKernan, RN
11:45 AM - 12:45 PM MDT Abstract 1-006 - Implementation of Electronic Health Record-based Anxiety and Depression Screening in an Epilepsy Clinic: Description of Theory-based Implementation Strategy and Quantitative Outcomes Using RE-AIM
Paneeni Lohana, DO
11:45 AM - 12:45 PM MDT Abstract 1-007 - Treatment Outcomes and Healthcare Resource Utilization Among People Living with Focal Onset Epilepsy and Deemed to be Drug Resistant in Clinical Practices in the United States
Jiainbin Mao
11:45 AM - 12:45 PM MDT Abstract 1-008 - Epidemiology of Drug-resistant Epilepsy in Latin America and the Caribbean: Systematic Review Update and Meta-analysis
Niels V. Pacheco, MD
11:45 AM - 12:45 PM MDT Abstract 1-009 - Does Discharge Diagnosis Determine Risk of Death? Mortality Following Admission to Veterans Health Administration (VHA) Epilepsy Centers of Excellence (ECoE) Epilepsy Monitoring Units (EMUs)
Marissa Kellogg, MD, MPH, FAAN
11:45 AM - 12:45 PM MDT Abstract 1-010 - Understanding Burden and Health Outcomes Based on Number of Adverse Events in Patients with Lennox-Gastaut Syndrome in Real-world Clinical Practice Settings
Arturo I. Benitez, MD
11:45 AM - 12:45 PM MDT Abstract 1-011 - Incidence of Epilepsy and Results of EEG Testing Within 10 Years of Stroke in US Veterans: A Single-center Cohort Study
Marissa Kellogg, MD, MPH, FAAN
11:45 AM - 12:45 PM MDT Abstract 1-012 - Evaluation of a Structured Acute Seizure Action Plan in an Outpatient Adult Epilepsy Center
Lucretia Long, DNP, APRN-CNP, FAES
11:45 AM - 12:45 PM MDT Abstract 1-014 - Making the Diagnosis
Shigeru Kaneki
11:45 AM - 12:45 PM MDT Abstract 1-015 - Assessing Cognitive Impairment in Patients with Epilepsy Using the Montreal Cognitive Assessment (MoCA)
Zaid S. Miqdadi
11:45 AM - 12:45 PM MDT Abstract 1-016 - Management of Anti-seizure Medication in Patients with Drug-resistant Focal Epilepsy Secondary to Focal Cortical Dysplasia Undergoing Epilepsy Surgery in Argentina
Rodrigo Sanjinez, Sr., MD
11:45 AM - 12:45 PM MDT Abstract 10-005 - Papilledema a “Misnomer” for Optic Disc Edema: A Single Center Analysis
Nicholas Demas
11:45 AM - 12:45 PM MDT Abstract 10-006 - Treatment Options for Acute/Subacute Patients with m.11778G>A MT-ND4 Leber Hereditary Optic Neuropathy: A Meta-analysis
Nancy J. Newman, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 4-001 - Structural Connectivity Changes in Brain Network After Spinal Cord Injury
Mario Minor Murakami, Jr., MD
11:45 AM - 12:45 PM MDT Abstract 4-002 - Face Validity: Digital Facial Analysis Recapitulates Clinical Findings of Neurological Disease
Alyssa Nylander, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 4-003 - Classification of Subvocalized Letters with a Neural Network Algorithm
Shaumprovo Debnath
11:45 AM - 12:45 PM MDT Abstract 4-004 - Expanding the Lesion Network Mapping of Delusions
Austin Flitton
11:45 AM - 12:45 PM MDT Abstract 4-005 - Remote Monitoring of Motor, Speech, and Cognitive Function in Progressive Supranuclear Palsy
Ram Kinker Mishra, PhD
11:45 AM - 12:45 PM MDT Abstract 4-006 - Exploring Neurophysiology Through Monitoring the ICP Waveforms in Shunted Pregnant Patients with a Non-invasive Device - A Case Series
Raphael Besborodco, MD
11:45 AM - 12:45 PM MDT Abstract 4-007 - Functional Neuronal Networks After Cortical Spreading Depolarizations
Miran Oncel, MD
11:45 AM - 12:45 PM MDT Abstract 4-008 - Brain Networks Implicated in Cerebral Achromatopsia
Mazzy F. Marcucci
11:45 AM - 12:45 PM MDT Abstract 4-009 - Brain Cortical Thickness Across Age and Gender: Data from Ethnically Diverse Cohort of 8,624 Individuals
Sam Hashemi
11:45 AM - 12:45 PM MDT Abstract 4-010 - The Relationship Between Follow-up MRI and Clinical Outcome in Patients with Encephalitis in a Large Academic Hospital
Jorge Cervantes
11:45 AM - 12:45 PM MDT Abstract 4-011 - A Pilot Study to Evaluate the Influence of a Clinician Outreach Effort for VUS Resolution in Limb-Girdle Muscular Dystrophy
Tanya Bardakjian
11:45 AM - 12:45 PM MDT Abstract 4-012 - Postoperative Cervical Spine Radiograph Analysis: Generative Adversarial Networks Which Erase Spinal Instrumentation Improve the Performance of Landmark Detection Models
Yunting Yu, MD
11:45 AM - 12:45 PM MDT Abstract 4-013 - Prospective Study of Extracellular Vesicles in Plasma as Potential Biomarkers for Silent Brain Infarcts
Lincey A. Wilson, MD
11:45 AM - 12:45 PM MDT Abstract 13-001 - Neuroinvasion of Emerging and Re-emerging Arboviruses: A Scoping Review
Bahadar S. Srichawla, DO, MS
11:45 AM - 12:45 PM MDT Abstract 13-002 - Cross-reactivity Between Powassan Virus and West Nile Virus in Patients with Encephalitis
Jeffrey Chen, MD
11:45 AM - 12:45 PM MDT Abstract 13-003 - West Nile Virus Rhombencephalitis Mimicking Hypertrophic Olivary Degeneration
Amanda Rubin, DO
11:45 AM - 12:45 PM MDT Abstract 13-004 - EMG Confirmed Axon Motor Polyneuropathy in a Patient with West Nile Virus: A Case Report
Paul Partyka, DO, PhD
11:45 AM - 12:45 PM MDT Abstract 13-005 - West Nile Virus, The New Great Mimic: A Case Series of Neuroinvasive WNV
DaYoung Kim, DO
11:45 AM - 12:45 PM MDT Abstract 13-006 - Complex Case of Neuroinvasive West Nile Virus
Danah Bakir, MD
11:45 AM - 12:45 PM MDT Abstract 13-007 - More than Meets the Eye: An Unusual Case of Opsoclonus-Myoclonus Syndrome Due to West-Nile Virus Encephalitis
Gavin DeFisser
11:45 AM - 12:45 PM MDT Abstract 13-008 - Powassan Virus Encephalitis in Pediatric Patients: A Case Series
Celia Greenlaw, MD
11:45 AM - 12:45 PM MDT Abstract 13-009 - Powassan Virus Infection Presenting as Rapidly Progressive Encephalitis and New-onset Refractory Status Epilepticus (NORSE)
Jenifer Moceri, DO
11:45 AM - 12:45 PM MDT Abstract 13-010 - East Coast Meets West Coast: A Pennsylvania Case of California Encephalitis with Bilateral Thalamic and Basal Ganglia Lesions
Sathvik S. Shastry, MD
11:45 AM - 12:45 PM MDT Abstract 5-001 - A Brain to Heart Chat - Improving Workflows of Implantable Loop Recorder for Cryptogenic Strokes
Yasodara Priyadharsi Senthamarai Siddharthan, MBBS
11:45 AM - 12:45 PM MDT Abstract 5-002 - The Role of microRNAs as Super-early Biomarkers in Acute Ischemic Stroke: Preliminary Data Analysis of a Systematic Review
John Demir
11:45 AM - 12:45 PM MDT Abstract 5-003 - Magnitude of Effect of Low Dose Colchicine, a Newly FDA Approved Treatment for Stroke Prevention
Erica Escalera
11:45 AM - 12:45 PM MDT Abstract 5-004 - Radiomic-based Risk Stratification of Intracranial Aneurysms
Elena Sagues, MD
11:45 AM - 12:45 PM MDT Abstract 5-006 - Large Artery Atherosclerosis and Young Stroke
Himanshu A. Patel, MD
11:45 AM - 12:45 PM MDT Abstract 5-007 - Caroticocavernous Fistulae: A Real World Comparison of Clinicoradiographic Features and Treatment Approaches
Justin Vranic
11:45 AM - 12:45 PM MDT Abstract 5-008 - Low-field, Portable Magnetic Resonance Imaging to Assess Hematoma Volume in Traumatic Brain Injury Patients
Julia Zabinska
11:45 AM - 12:45 PM MDT Abstract 5-009 - Impact of Socioeconomic Status on Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage
Ariyaporn Haripottawekul
11:45 AM - 12:45 PM MDT Abstract 5-011 - Patent Foramen Ovale Closure for Secondary Stroke Prevention in Patients Aged 60 or Older Is Safe
Brandon May, MD
11:45 AM - 12:45 PM MDT Abstract 5-012 - Susac’s Syndrome, a Rare Cause of Multifocal Neurologic Deficits: A Case Report
Taylor R. Anderson, MD
11:45 AM - 12:45 PM MDT Abstract 5-014 - Stroke Etiology in Young Adults with Substance Abuse
Himanshu A. Patel, MD
11:45 AM - 12:45 PM MDT Abstract 5-015 - Collateral Recruitment and Thrombocytosis in Patients with Acute Embolic Stroke
Mohammed K. Badi, MD
11:45 AM - 12:45 PM MDT Abstract 5-018 - DADA2 Syndrome Causing Cerebrovascular Ischemic Syndromes in Two Asian Siblings
Yongyao Kong, MBBS
11:45 AM - 12:45 PM MDT Abstract 5-019 - Assessing Effects of Intrathecal Nicardipine on Cerebral Autoregulation and Cortical Activity in Aneurysmal Subarachnoid Hemorrhage
Sithmi M. Jayasundara
11:45 AM - 12:45 PM MDT Abstract 5-020 - Light-induced Amaurosis Fugax
David Koren, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 5-021 - Prolonged and Reversible Encephalopathy Secondary to an Arteriovenous Fistula: A Case Report
Zahid Iqbal, MD
11:45 AM - 12:45 PM MDT Abstract 5-022 - Insights into Stroke in Young Adults at a Tertiary Care Level Hospital in Nariño, Colombia: A Four-year Retrospective Analysis
Andres Ricaurte, MD
11:45 AM - 12:45 PM MDT Abstract 5-023 - Clopidogrel Versus Ticagrelor in Dual Antiplatelet Therapy for Intracranial Aneurysm Patients Undergoing Neuroendovascular Treatment: A Systematic Review and Meta-analysis
Ahmed Negida, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 5-024 - Improving Cerebrovascular Reactivity After Carotid Endarterectomy Is Not Accompanied by Improvement in Endothelial Vasodilator Function
Lauri S. Soinne, MD, PhD, FAAN
11:45 AM - 12:45 PM MDT Abstract 5-025 - Does Frontal Lobe Stroke Influence the Development of Post-stroke Fatigue?
Tyler Spohr, MD
11:45 AM - 12:45 PM MDT Abstract 5-026 - Triglyceride-glucose Index as a Marker for Insulin Resistance and its Association with CTA Collaterals in Acute Ischemic Stroke: A Retrospective Cohort Study
Mohammed Qussay Ali Al-Sabbagh, MD
11:45 AM - 12:45 PM MDT Abstract 5-027 - Quality Improvement Project for Improving Adherence to ICH Severity Documentation Using RapidAI
Vinay Lakki, MBBS
11:45 AM - 12:45 PM MDT Abstract 5-028 - Older Age Is Associated with Frequent Clinical-core Mismatch in Stroke due to Anterior Circulation Large Vessel Occlusion
Lucas Rios Rocha, MD
11:45 AM - 12:45 PM MDT Abstract 5-030 - Paroxysmal Nocturnal Hemoglobinuria: A Rare Cause of Ischemic Stroke
Nicholas Bascou, MD
11:45 AM - 12:45 PM MDT Abstract 5-031 - Comparison of Drug-eluting Stents with Bare Metal Stents for the Treatment of Intracranial and Extracranial Atherosclerotic Stenosis: A Systematic Review and Meta-analysis
Sayed Mustafa M. Shah, MBBS
11:45 AM - 12:45 PM MDT Abstract 5-032 - Recurrent Embolic Ischemic Infarcts with Eosinophilia
Kyle Distler
11:45 AM - 12:45 PM MDT Abstract 2-001 - The Association of Social Determinants of Health on Functional Outcome After Intracerebral Hemorrhage
Akashleena Mallick, MD, MBBS
11:45 AM - 12:45 PM MDT Abstract 2-002 - The Fragility Index of Randomized Controlled Trials for Early Blood Pressure Management of Intracerebral Hemorrhage
Cesar E. Escamilla-Ocanas, MD
11:45 AM - 12:45 PM MDT Abstract 2-004 - Different Response to Blood Pressure Reduction in Lobar and Deep Intracerebral Hemorrhage
Maximiliano A. Hawkes, MD
11:45 AM - 12:45 PM MDT Abstract 2-005 - Striking Multi-focal Diffusion Restriction with Intracranial Hypertension—Is It CHANTER Syndrome?
Syed Muhammad Owais
11:45 AM - 12:45 PM MDT Abstract 2-006 - Eye Movement Detection Using Electrooculography and Machine Learning in Cardiac Arrest Patients
Chelsea Sykora, MD
11:45 AM - 12:45 PM MDT Abstract 11-001 - Treatment Fluctuations in Patients with Acetylcholine Receptor Antibody Positive Generalized Myasthenia Gravis on Maintenance Ravulizumab Treatment
Dave S. Ho, MD
11:45 AM - 12:45 PM MDT Abstract 11-002 - Effectiveness and Safety of Transitioning to Ravulizumab from Eculizumab in Patients with Generalized Myasthenia Gravis: Evidence from a Global Registry
Guido Sabatella
11:45 AM - 12:45 PM MDT Abstract 11-003 - Drivers of New Rozanolixizumab Treatment Cycles in Patients with Generalized Myasthenia Gravis in the Phase 3 MycarinG and Open-label Extension Studies
Tuan H. Vu, MD
11:45 AM - 12:45 PM MDT Abstract 11-004 - Phase 1 Study of Gefurulimab Pharmacokinetics (PK) and Safety Following Delivery Via Autoinjector in Healthy Adults
Olivia Tong, MD
11:45 AM - 12:45 PM MDT Abstract 11-005 - Response to Rozanolixizumab Across Treatment Cycles in Patients with Generalized Myasthenia Gravis: A Post-hoc Analysis
Robert M. Pascuzzi, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 11-006 - Safety, Efficacy, and Patient Preference for Subcutaneous Zilucoplan in Myasthenia Gravis After Switching from Intravenous Complement Component 5 Inhibitors: An Interim Analysis of a Phase 3b Study
Miriam L. Freimer, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 11-007 - Analysis of Serious Infections and Malignancy Risk in Myasthenia Gravis: A US Claims Database Study
Jana Podhorna
11:45 AM - 12:45 PM MDT Abstract 11-008 - Long-term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Participants with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC+ Study
James F. Howard, Jr., MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 11-009 - Achievement of Minimal Symptom Expression and Effect on Disease-specific Measures in Acetylcholine Receptor Antibody-positive Participants with Generalized Myasthenia Gravis Treated with Efgartigimod in ADAPT/ADAPT+
Srikanth Muppidi, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 11-010 - Fixed-cycle and Continuous Dosing of Intravenous Efgartigimod for Generalized Myasthenia Gravis: Study Design of ADAPT NXT
Vera Bril, MD
11:45 AM - 12:45 PM MDT Abstract 11-011 - Patterns of Steroid Use and Outcomes in US Patients with Generalized Myasthenia Gravis (gMG) Receiving C5 Inhibitor Therapy (C5IT)
Karen Yee, PhD
11:45 AM - 12:45 PM MDT Abstract 11-012 - Mortality and Cancer Risk in Patients with Myasthenia Gravis (MG): A Retrospective Study
Shahar Shelly, MD
11:45 AM - 12:45 PM MDT Abstract 11-013 - Initial Development of the Myasthenia Gravis-Health Index (MG-HI): Measuring the Most Prevalent and Impactful Symptoms Identified in Myasthenia Gravis
Charlotte Engebrecht
11:45 AM - 12:45 PM MDT Abstract 11-014 - Effect of Applying Inclusion and Exclusion Criteria of Phase III Complement Inhibitor and FCRN Inhibitor Trials to Acetylcholine Receptor-positive Generalized Myasthenia Gravis Patients in Routine Clinical Care
Nakul Katyal, MD
11:45 AM - 12:45 PM MDT Abstract 11-015 - LUMINESCE, a Phase 3 Study of Satralizumab in Generalized Myasthenia Gravis (gMG): Baseline Characteristics
Ivana Vodopivec, MD
11:45 AM - 12:45 PM MDT Abstract 11-017 - Anti-IL-6 Receptor Antibody Prevents Muscle Weakness in Experimental Autoimmune Myasthenia Gravis Mouse Model
Shota Miyake
11:45 AM - 12:45 PM MDT Abstract 11-018 - Management of Myasthenia Gravis Around the Globe: Consensus Guidelines vs. Realities of Practice
Julia Greenberg, MD
11:45 AM - 12:45 PM MDT Abstract 11-019 - Sentiment Analysis of Digital Conversations Related to Myasthenia Gravis by Race/Ethnicity
Louis Jackson, PharmD
11:45 AM - 12:45 PM MDT Abstract 11-020 - Investigating Immunological Profiles of Thymus in Myasthenia Gravis by scRNA-seq
Yingkai Li, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 14-001 - Validation Process of NMOSDCopilotTM, a Software as a Medical Device (SaMD) for Patients Living with Neuromyelitis Optica Spectrum Disorder
Michael Levy, MD, PhD, FAAN
11:45 AM - 12:45 PM MDT Abstract 14-002 - Burdens of Neuromyelitis Optica Spectrum Disorder: Real-world Perspectives from Caregivers
Shervin Gholizadeh
11:45 AM - 12:45 PM MDT Abstract 14-003 - Infection in NMOSD: Analyzing the Patterns of Infection in the SAkura Studies, Satralizumab Post-marketing Data, and NMOSD US PharMetrics Claims Data
Benjamin M. Greenberg, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 14-004 - Application of NMOSD IPND-2015 Criteria in AQP4-IgG Positive, MOG-IgG Positive and Seronegative Inflammatory Demyelinating Diseases
Samira Apostolos-Pereira
11:45 AM - 12:45 PM MDT Abstract 14-005 - Indirect Treatment Comparison of Ravulizumab Versus Approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-Positive (AQP4-IgG+) Neuromyelitis Optica Spectrum Disorder (NMOSD)
Stacey Clardy, MD, PhD, FAAN
11:45 AM - 12:45 PM MDT Abstract 14-006 - Matching-adjusted Indirect Comparison of Current Treatments for NMOSD and Evaluation of Long-term Effectiveness
Friedemann Paul
11:45 AM - 12:45 PM MDT Abstract 14-007 - Depression and Anxiety in Neuromyelitis Optica Spectrum Disease (NMOSD): Analysis of a National Dataset
Esther Zeng
11:45 AM - 12:45 PM MDT Abstract 14-008 - The Remarkable Efficacy of Topiramate in Treating Oscillopsia in Neuromyelitis Optica Spectrum Disorder: A Video Case Report
Yuanyuan Tan, MD
11:45 AM - 12:45 PM MDT Abstract 14-009 - Eculizumab Therapy in a Seronegative Patient with NMOSD: A Case Report
Alejandra Duque Ramirez, MD
11:45 AM - 12:45 PM MDT Abstract 14-010 - Trends in Management Practices of Seropositive Neuromyelitis Optica Spectrum Disorder: Lessons from a Multicenter Academic Cohort
Leah Zuroff, MD
11:45 AM - 12:45 PM MDT Abstract 14-011 - Frequency of Neuromyelitis Optica Spectrum Disorder Correlated Symptoms: A Pre- and Post-diagnosis Comparison from a National Dataset
Abigail H. Sorenson
11:45 AM - 12:45 PM MDT Abstract 14-012 - Transient Neutrophilic Pleocytosis and Hypoglycorrhachia in a Case of Neuromyelitis Optica Spectrum Disorder
Shouri Dirks, MD
11:45 AM - 12:45 PM MDT Abstract 14-013 - Epidemiology of Seropositive Neuromyelitis Optica Spectrum Disorder in a Large US Population
Carlos Eduardo Vervloet Sollero, MD
11:45 AM - 12:45 PM MDT Abstract 14-014 - Fulminant Paraneoplastic Neuromyelitis Optica Spectrum Disorder (NMOSD) with Triple-negative, Aquaporin-4-positive Breast Cancer
Hemali Patel, DO
11:45 AM - 12:45 PM MDT Abstract 14-016 - Relapse Determinants in Seropositive and Seronegative Neuromyelitis Optica Spectrum Disorder
Pakeeran Siriratnam, MBBS
11:45 AM - 12:45 PM MDT Abstract 14-017 - Descriptive Analysis of Clinical Presentation in a Caribbean Hispanic Population with Neuromyelitis Optica Spectrum Disorders (NMO-SD)
Marelisa Albelo Martinez, MD
11:45 AM - 12:45 PM MDT Abstract 14-018 - Importance of Bodily Functions in Neuromyelitis Optica Spectrum Disorder from Neurologists’ Perspective
Rocío Gómez, Other
11:45 AM - 12:45 PM MDT Abstract 14-019 - NMOSD Patients Transitioning from Adolescent to Adult Care: A Multi-institutional Database Analysis in the United States
Melissa A. Wright, MD
11:45 AM - 12:45 PM MDT Abstract 14-020 - Evaluation of Subcortical Pathology and Association with Cognition in Neuromyelitis Optica Spectrum Disorders with Myelin Water Imaging
Wendy Tsai, MD
11:45 AM - 12:45 PM MDT Abstract 8-001 - Disparities in Timely Child Neurology Outpatient Care Post-inpatient Admission
Alexander Zhao
11:45 AM - 12:45 PM MDT Abstract 8-003 - What Happens After Hemispherectomy? A Qualitative Study of Parental Narratives
Meredith F. Yang
11:45 AM - 12:45 PM MDT Abstract 8-004 - Social Determinants of Health (SDOH) and Context in Initial Access, Symptom Report, and Recovery within Pediatric Mild Traumatic Brain Injury (mTBI) Care
Sydney A. Wing, PhD
11:45 AM - 12:45 PM MDT Abstract 8-005 - Functional Goal Setting for Botulinum Toxin Injections in People with Cerebral Palsy
Laura Gilbert, DO, MBA
11:45 AM - 12:45 PM MDT Abstract 8-006 - Improving Detection of Underlying Neurologic Etiology for Pediatric Cavovarus Foot Deformity: We Can Do Better
Michelle R. Christie, MD
11:45 AM - 12:45 PM MDT Abstract 8-007 - Case Report: Gait Abnormality as a Presenting Symptom of Scurvy
Sydney N. Carnes, MD
11:45 AM - 12:45 PM MDT Abstract 8-008 - Healthcare Providers’ Practice and Perception on Discussing Life Expectancy with Duchenne Patients and Caregivers: A Mixed Quantitative/Qualitative Survey
Lauren Treat, MD
Faculty Disclosures
No disclosure on file
Deap S. Bhandal Mr. Bhandal has received research support from Health Resources and Services Administration.
Devin M. Davies Mr. Davies has received research support from Health Resources and Services Administration.
Kathleen Spears No disclosure on file
Dustin Carpenter No disclosure on file
Mohammed A. Hussain, MD No disclosure on file
Ada Breitenbucher, MD Dr. Breitenbucher has nothing to disclose.
Yazan Al-Hasan, MD, PhD Dr. Al-Hasan has nothing to disclose.
Justin Hoskin, MD Dr. Hoskin has nothing to disclose.
Stephen Foldes No disclosure on file
Vladimir Shvarts, MD Dr. Shvarts has nothing to disclose.
Mohammad Moussavi, MD Dr. Moussavi has nothing to disclose.
Kanchan Kumari, MBBS Dr. Kumari has nothing to disclose.
Gabriella Rizzo, MD Dr. Rizzo has nothing to disclose.
Daniel Zhou, MD The institution of Dr. Zhou has received research support from American Epilepsy Society. The institution of Dr. Zhou has received research support from National Institutes of Health.
Kaeli Samson No disclosure on file
Daniel L. Murman, MD, FAAN The institution of Dr. Murman has received research support from Biogen. The institution of Dr. Murman has received research support from EIP Pharma. The institution of Dr. Murman has received research support from Eli Lilly & Co.. The institution of Dr. Murman has received research support from Functional Neuromodulation. The institution of Dr. Murman has received research support from Roche Pharmaceuticals.
Jawad F. Kirmani, MD Dr. Kirmani has nothing to disclose.
Gregory S. Day, MD, MSc, FAAN Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has or had stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with 好色先生. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing 好色先生, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a 好色先生al Case Development + Presentation (video) with PeerDirect (P\S\L Group). Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development / Presentation (non-CME) with MJH Life Sciences (NeurologyLive). Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Neill R. Graff-Radford, MD, FAAN The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Nihal Satyadev, MD, MPH Dr. Satyadev has nothing to disclose.
Philip W. Tipton, MD Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Alzheimer's Tennessee. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Charlotte County Medical Society, Inc.
Aaron L. Berkowitz, MD, PhD, FAAN Dr. Berkowitz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Berkowitz has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw-Hill 好色先生. Dr. Berkowitz has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received personal compensation in the range of $500-$4,999 for serving as a Content creator with Clinical problem Solvers. Dr. Berkowitz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Thieme Publisher.
David Galarneau No disclosure on file
Marlie Winslow, MD Ms. Winslow has nothing to disclose.
M. B. Westover, MD, PhD Dr. Westover has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Beacon Biosignals. Dr. Westover has stock in Beacon Biosignals. The institution of Dr. Westover has received research support from NIH. Dr. Westover has received publishing royalties from a publication relating to health care. Dr. Westover has a non-compensated relationship as a cofounder with Beacon Biosignals that is relevant to AAN interests or activities.
Tahlia Bragg No disclosure on file
Shania Baldwin No disclosure on file
Minna Holleck No disclosure on file
Erika Pettway No disclosure on file
Fatima Tuz-Zahra No disclosure on file
Yorghos Tripodis Yorghos Tripodis has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association.
Charles Bernick, MD Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Optina. Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corium. Dr. Bernick has stock in Aurora. The institution of Dr. Bernick has received research support from UFC. The institution of Dr. Bernick has received research support from Top Rank Promotions. The institution of Dr. Bernick has received research support from Haymon Boxing.
Laura J. Balcer, MD, MSCE, FAAN An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Charles H. Adler, MD, PhD, FAAN Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Jeffrey L. Cummings, MD, FAAN Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia, Actinogen, Acumen, AlphaCognition, ALZpath, Aprinoia, AriBio, Artery, Biogen, Biohaven, BioVie, BioXcel, Bristol-Myers Squib, Cassava, Cerecin, Diadem, Eisai, GAP Foundation, GemVax, Janssen, Jocasta, Karuna, Lighthouse, Lilly, Lundbeck, LSP/eqt, Mangrove Therapeutics, Merck, NervGen, New Amsterdam, Novo Nordisk, Oligomerix, ONO, Optoceutics, Otsuka, Oxford Brain Diagnostics, Prothena, ReMYND, Roche, Sage Therapeutics, Signant Health, Simcere, sinaptica, Suven, TrueBinding, Vaxxinity, and Wren pharmaceutical, assessment, and investment companies. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia, Biogen, Genentech, Grifols, Janssen, Karuna, Otsuka, reMYND, Roche, Signant Health. Dr. Cummings has stock in Artery, Vaxxinity, Behrens, Alzheon, MedAvante-Prophase, and Acumen. Dr. Cummings has received research support from NIH. Dr. Cummings has received research support from NIGMS. Dr. Cummings has received intellectual property interests from a discovery or technology relating to health care.
Eric M. Reiman, MD Dr. Reiman has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Denali, Green Valley, Zinfandel, and Takeda. Dr. Reiman has received stock or an ownership interest from Alkahest, Alzheon, Aural Analytics, Denali, and United Neuroscience.. Dr. Reiman has received intellectual property interests from a discovery or technology relating to health care. Dr. Reiman has received personal compensation in the range of $500-$4,999 for serving as a Member, National Advisory Council on Aging (NACA) with NIA.
Martha Shenton Martha Shenton has nothing to disclose.
Robert Stern, PhD Robert Stern, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Robert Stern, PhD has received research support from Eisai. The institution of Robert Stern, PhD has received research support from Lilly. The institution of Robert Stern, PhD has received research support from ATRI/NIA. Robert Stern, PhD has received publishing royalties from a publication relating to health care. Robert Stern, PhD has a non-compensated relationship as a Member with NFLPA Mackey-White Committee that is relevant to AAN interests or activities.
Michael Alosco, PhD The institution of Michael Alosco, PhD has received research support from NIH. The institution of Michael Alosco, PhD has received research support from Life Molecular Imaging Inc.
Robert Turner No disclosure on file
Aaron Ritter, MD The institution of Dr. Ritter has received research support from NIH.
Michael Levy, MD, PhD, FAAN Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
Elias S. Sotirchos, MD Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Sotirchos has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Sotirchos has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Sotirchos has received research support from National Institutes of Health. The institution of Dr. Sotirchos has received research support from National Multiple Sclerosis Society. The institution of Dr. Sotirchos has received research support from Sumaira Foundation. The institution of Dr. Sotirchos has received research support from Genentech. The institution of Dr. Sotirchos has received research support from UCB. The institution of Dr. Sotirchos has received research support from Astoria Biologica. The institution of Dr. Sotirchos has received research support from Ad Scientiam. The institution of Dr. Sotirchos has received research support from Alexion. The institution of Dr. Sotirchos has received research support from Corevitas. Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving as a Ad Hoc Reviewer with National Institutes of Health.
Loic Carment Loic Carment has received personal compensation for serving as an employee of Ad Scientiam.
Clarissa Gorin, Other Dr. Gorin has received personal compensation for serving as an employee of Ad Scientiam.
Lissandra Klaeylé Lissandra Klaeylé has received personal compensation for serving as an employee of Ad Scientiam.
Dellini Ravindra Dellini Ravindra has received personal compensation for serving as an employee of Ad Scientiam.
Emma Touré Cuq No disclosure on file
Alizé Vives No disclosure on file
Saad Zinai Saad Zinai has received personal compensation for serving as an employee of AD Scientiam. Saad Zinai has stock in Ad Scientiam.
Jerome De Seze Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma.
Anisha Patel, PhD Dr. Patel has received personal compensation for serving as an employee of Genentech. An immediate family member of Dr. Patel has received personal compensation for serving as an employee of Google. Dr. Patel has stock in Genentech Inc.. An immediate family member of Dr. Patel has stock in Google.
Kathryn Krupsky No disclosure on file
Ashley Martin No disclosure on file
Kacper Perkowski No disclosure on file
Patrick Olsen No disclosure on file
Shervin Gholizadeh Mr. Gholizadeh has received personal compensation for serving as an employee of Genentech.
Jacinta Behne Ms. Behne has nothing to disclose.
Megan Behne Ms. Behne has received personal compensation for serving as an employee of The Guthy-Jackson Charitable Foundation. Ms. Behne has received personal compensation in the range of $50,000-$99,999 for serving as a Independent Contractor with The Guthy-Jackson Charitable Foundation.
Kim Jackson-Matthews No disclosure on file
Lisa McDaniel No disclosure on file
Cori Woolf No disclosure on file
Michael R. Yeaman, PhD Dr. Yeaman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Yeaman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech-Roche. Dr. Yeaman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Yeaman has received research support from National Institutes of Health. The institution of Dr. Yeaman has received research support from U.S. Department of Defense. Dr. Yeaman has received intellectual property interests from a discovery or technology relating to health care. Dr. Yeaman has received intellectual property interests from a discovery or technology relating to health care.
Lindsay Rechtman The institution of Lindsay Rechtman has received research support from ATSDR.
Kazuo Fujihara, MD Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Boipharma. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Japan Tobacco. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai/Roche. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Fujihara has received research support from Ministry of Health, Welfare and Labor of Japan. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a speaker, chair, etc with Novartis. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving as a speaker, chair, etc with Biogen. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a speaker, chair, etc with Mitsubishi-Tanabe. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a apeaker, chair, etc with Chugai/Roche. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker, chair, etc with Alexion. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a chair, speaker with Asahi Kasei Medical. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker with Eisai. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker, chair with Teijin.
Brian G. Weinshenker, MD, FAAN Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zenas Pharma. Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care.
Francesco Patti, MD Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Almirall. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Almirall, Bayer, Biogen, Bristol Meyers and Squibb Merck, Roche, Sanofi, TEVA. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for University of Catania and AISM/FISM, Fondazione Italiana Sclerosi Multipla. Dr. Patti has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
Ingo Kleiter Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall.
Jacqueline Palace Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono, Medimmune, Argenx, Janssen, AMgen, UCB, Roche, Novartis, Amplo, Alexion, . Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx, Sanofi. Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche, UCB, Alexion, Amgen. Dr. Palace has or had stock in Astra Zenica. The institution of Dr. Palace has received research support from Roche, AMPLO, Alexion, UCB,. argenx, amgen. Dr. Palace has received intellectual property interests from a discovery or technology relating to health care.
Miriam Triyatni Miriam Triyatni has received personal compensation for serving as an employee of Hoffmann-La Roche Inc. Miriam Triyatni has stock in F-Hoffmann La Roche Inc.
Kathleen Blondeau No disclosure on file
Alexander Burdeska No disclosure on file
INNOCENT NGWA No disclosure on file
Takashi Yamamura, MD Dr. Yamamura has nothing to disclose.
Benjamin M. Greenberg, MD, FAAN Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has or had stock in GenrAb.Dr. Greenberg has or had stock in Clene.Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Gaelle Klingelschmitt Gaelle Klingelschmitt has received personal compensation for serving as an employee of F.Hoffmann-La Roche LTD.
Jeffrey L. Bennett, MD, PhD, FAAN Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immpact Bio. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chugai. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beigene. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIAC. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Bennett has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vindico. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Touch IME. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Efficient LLC. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pavich. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Marie Bush. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Marks Gray. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Knight, Nicastro, MacKay. The institution of Dr. Bennett has received research support from Alexion. The institution of Dr. Bennett has received research support from Genentech. Dr. Bennett has received intellectual property interests from a discovery or technology relating to health care. Dr. Bennett has received publishing royalties from a publication relating to health care.
Wendy E. Kaye, PhD Dr. Kaye has received personal compensation for serving as an employee of McKing Consulting Corporation. Dr. Kaye has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Association for the Protection of Human Research Participants.
Samira Apostolos-Pereira Samira Apostolos-Pereira has nothing to disclose.
Joao Vitor Mahler, MD Dr. Mahler has received research support from The Sumaira Foundation.
Guilherme Diogo Silva No disclosure on file
Vinicius A. Schoeps, MD Dr. Schoeps has nothing to disclose.
Ana Beatriz Ayroza Galvao Ribeiro Gomes, MD Dr. Ayroza Galvao Ribeiro Gomes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Guidepoint. The institution of Dr. Ayroza Galvao Ribeiro Gomes has received research support from Roche.
Natalia T. Mendes, MD Dr. Mendes has nothing to disclose.
Aline d. Matos, MD The institution of Dr. Matos has received research support from Hoffmann LaRoche.
Marina Solti, MD Dr. Solti has nothing to disclose.
Milena Pitombeira No disclosure on file
Mateus Boaventura de Olivei, MD Dr. Boaventura de Olivei has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Boaventura de Olivei has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche.
CAROLINA Rimkus No disclosure on file
Tarso Adoni, MD, PhD, FAAN Dr. Adoni has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Adoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Adoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Adoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Anne-Katrin Proebstel, MD The institution of Dr. Proebstel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Proebstel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Proebstel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Proebstel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Proebstel has received research support from Biogen. Dr. Proebstel has received intellectual property interests from a discovery or technology relating to health care.
Douglas K. Sato, MD Dr. Sato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra-Zeneca. The institution of Dr. Sato has received research support from Biogen. The institution of Dr. Sato has received research support from Merck.
Dagoberto Callegaro, Sr., PhD Dr. Callegaro has nothing to disclose.
Renata Paolilo Renata Paolilo has nothing to disclose.
Pedro B. Torretta, MD Dr. Torretta has nothing to disclose.
Robert L. Carruthers, MD Dr. Carruthers has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Carruthers has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche and Genentech. The institution of Dr. Carruthers has received research support from Roche and Genentech .
Stacey Clardy, MD, PhD, FAAN Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
Sean J. Pittock, MD, FAAN Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Orhan Aktas, MD Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen/Horizon. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubish Tanake. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen/Horizon. The institution of Dr. Aktas has received research support from German Research Foundation. The institution of Dr. Aktas has received research support from German Ministry of Science. The institution of Dr. Aktas has received research support from Neuromyelitis optica Study Group (NEMOS).
Jin Nakahara, MD, PhD, FAAN Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Prof. Nakahara has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Chugai. Prof. Nakahara has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Mitsubishi-Tanabe. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Japanese Society for Internal Medicine. The institution of Prof. Nakahara has received research support from Chugai. The institution of Prof. Nakahara has received research support from Japan Society for the Promotion of Science.
Noriko Isobe, MD Dr. Isobe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion Pharma. Dr. Isobe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Chugai Pharma . Dr. Isobe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe. Dr. Isobe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis Pharma. Dr. Isobe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Isobe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda Pharmaceutical. Dr. Isobe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichisankyo. Dr. Isobe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Isobe has received research support from Chugai Pharmaceutical. The institution of Dr. Isobe has received research support from Kyowa Kirin. The institution of Dr. Isobe has received research support from CSL Behring. The institution of Dr. Isobe has received research support from Boehringer Ingelheim. The institution of Dr. Isobe has received research support from Otsuka Pharma. The institution of Dr. Isobe has received research support from Sumitomo Pharmaceutical . The institution of Dr. Isobe has received research support from Eisai.
Diego Centonze Diego Centonze has nothing to disclose.
Jeroen Jansen No disclosure on file
Sami Fam Sami Fam has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Sami Fam has or had stock in Astra Zeneca.
Adrian Kielhorn Adrian Kielhorn has received personal compensation for serving as an employee of Alexion. Adrian Kielhorn has stock in Alexion.
Jeffrey Yu, PhD Dr. Yu has received personal compensation for serving as an employee of Alexion. Dr. Yu has stock in AstraZeneca.
Ina Zhang No disclosure on file
Tanuja Chitnis, MD, FAAN Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Friedemann Paul Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb GmbH & Co. KGaA (BMS. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for F&U Confirm. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb GesmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MICE Service. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VINDICO medical education. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Beijing Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz Internation GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Thailand. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology, Neuroimmunology&Neuroinflammation.
FRANCISCO Sorio Vilela No disclosure on file
Kristina R. Patterson, MD, PhD Dr. Patterson has received personal compensation for serving as an employee of Amgen. Dr. Patterson has stock in Amgen.
Bruce A. Cree, MD, PhD, MAS, FAAN The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Nishi Rampal, MD Dr. Rampal has received personal compensation for serving as an employee of Amgen. Dr. Rampal has received personal compensation for serving as an employee of Horizon Therapeutics. Dr. Rampal has stock in Amgen. Dr. Rampal has stock in Horizon Therapeutics.
Daniel M. Cimbora, PhD Dr. Cimbora has received personal compensation for serving as an employee of Amgen. Dr. Cimbora has received personal compensation for serving as an employee of Horizon Therapeutics. Dr. Cimbora has received personal compensation for serving as an employee of Viela Bio. Dr. Cimbora has stock in Amgen.
Mikkel Pedersen No disclosure on file
Brian C. Healy The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Esther Zeng Miss Zeng has nothing to disclose.
Abigail H. Sorenson Ms. Sorenson has nothing to disclose.
Melissa A. Wright, MD Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis .
Aditi Sharma No disclosure on file
Trieste Francis Miss Francis has nothing to disclose.
John W. Rose, MD, FAAN The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Ka-Ho Wong The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association.
Tammy L. Smith, MD, PhD Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Smith has received research support from Alexion/AstraZeneca.
Robert P. Lisak, MD, FAAN Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alivar Therapeutics. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ANI Pharmaceuticals. Dr. Lisak has received personal compensation in the range of $0-$499 for serving as a Consultant for Coleman Research. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tedus Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for COUR Pharma. The institution of Dr. Lisak has received research support from NINDS. The institution of Dr. Lisak has received research support from Argenx. The institution of Dr. Lisak has received research support from Ra Pharmaceuticals. Dr. Lisak has received publishing royalties from a publication relating to health care. Dr. Lisak has received publishing royalties from a publication relating to health care.
Mirla L. Avila, MD, FAAN Dr. Avila has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Genzyme, BMS, Serono. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen, genzyme, BMS. The institution of Dr. Avila has received research support from Texas Tech.
Yuanyuan Tan, MD Dr. Tan has nothing to disclose.
Alejandra Duque Ramirez, MD Dr. Duque Ramirez has nothing to disclose.
Rebecca Romero, MD, FAAN Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics . Dr. Romero has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon.
Hanane Touil, PhD No disclosure on file
Leah Zuroff, MD Dr. Zuroff has received personal compensation in the range of $500-$4,999 for serving as a Speaker with EMD Serono.
Jaeleene Wijangco Jaeleene Wijangco has nothing to disclose.
Rachel Brandstadter, MD Dr. Brandstadter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Myla D. Goldman, MD, MSc, FAAN Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentec. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis Pharmceuticals. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniska. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics Ltd., . Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Goldman has received personal compensation in the range of $0-$499 for serving as a Grant Review Committee Member with Department of Defense.
Edith Graham, MD Dr. Graham has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Graham has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Graham has received research support from F. Hoffman-La Roche Ltd. The institution of Dr. Graham has received research support from Novartis.
Rebecca Farber No disclosure on file
Leorah A. Freeman, MD, PhD Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Hoffman La-Roche. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Texas Neurological Society. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono/ Merck. The institution of Dr. Freeman has received research support from Genentech. The institution of Dr. Freeman has received research support from PCORI. The institution of Dr. Freeman has received research support from EMD Serono. The institution of Dr. Freeman has received research support from Sanofi. The institution of Dr. Freeman has received research support from MSAA. The institution of Dr. Freeman has received research support from National Multiple Sclerosis Society.
Navid Valizadeh, MBBS Dr. Valizadeh has nothing to disclose.
Riley Bove, MD, FAAN Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD-Serono. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadenza. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Eli Lilly. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Roche Genentech.
Dina Jacobs, MD Dr. Jacobs has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck/EMD Serono. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharmaceuticals. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi . Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for William Blair &Company . Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi . The institution of Dr. Jacobs has received research support from Roche/Genentech .
Xiyan Yi, MD Dr. Yi has nothing to disclose.
Shouri Dirks, MD Miss Dirks has nothing to disclose.
Jiannan Huang No disclosure on file
Baker Alkhairi No disclosure on file
Kavita Nair, PhD, FAAN Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PhRMA Foundation. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MJH Lifesciences. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anylam . Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Patient Experience. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MHJ Life Sciences. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for ICER. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Phrma Foundation. The institution of Dr. Nair has received research support from Bristol Meyers Squibb. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from NINDS. The institution of Dr. Nair has received research support from Sanofi Genzyme. The institution of Dr. Nair has received research support from Kyverna Therapeutcis. Dr. Nair has a non-compensated relationship as a Board Member with Center for Improving Value in Healthcare that is relevant to AAN interests or activities.
Aaron M. Carlson, MD Dr. Carlson has received research support from Horizon Therapeutics (Amgen).
Stefan Sillau Stefan Sillau has nothing to disclose.
Carlos Eduardo Vervloet Sollero, MD Dr. Vervloet Sollero has nothing to disclose.
Amanda L. Piquet, MD, FAAN The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna . The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cortez & Associates. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Falk Waas. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. The institution of Dr. Piquet has received research support from Kyverna . Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to AAN interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to AAN interests or activities.
Kelli Money, MD, PhD Dr. Money has nothing to disclose.
Barrie L. Zerwic, MD Dr. Schmitt has nothing to disclose.
Ibrahim Noorbhai, DO Dr. Noorbhai has nothing to disclose.
Fernando X. Cuascut Lassus, MD Dr. Cuascut Lassus has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Cuascut Lassus has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Cuascut Lassus has received personal compensation in the range of $500-$4,999 for serving as a Speaker with MSAA.
Joseph S. Kass, MD, JD, FAAN Dr. Kass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生 . Dr. Kass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Kass has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple Law Firms . Dr. Kass has received publishing royalties from a publication relating to health care.
Hemali Patel, DO Dr. Patel has nothing to disclose.
Rebeka Bustamante Rocha, Other Mrs. Bustamante Rocha has nothing to disclose.
Fernanda Bomtempo No disclosure on file
Ana Claudia Benevides Tadinac, MD No disclosure on file
Joao Paulo Telles Joao Paulo Telles has nothing to disclose.
Sharon Chiang, MD, PhD Dr. Chiang has stock in EpilepsyAI. Dr. Chiang has received research support from UCSF Clinical and Translational Science Institute UL1 TR001872. The institution of Dr. Chiang has received research support from NIH R25 NS070680 .
Pakeeran Siriratnam, MBBS Dr. Siriratnam has nothing to disclose.
Paul Sanfilippo No disclosure on file
Saif Huda, MD Dr. Huda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen.
Sifat Sharmin, PhD Dr. Sharmin has nothing to disclose.
Tomas Kalincik Tomas Kalincik has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Tomas Kalincik has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Health and Medical Research Council. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MS Research Australia. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Tomas Kalincik has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for WebMD Global. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for BioCSL. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Tomas Kalincik has received research support from Biogen. The institution of Tomas Kalincik has received research support from Novartis. The institution of Tomas Kalincik has received research support from Genzyme. The institution of Tomas Kalincik has received research support from Roche. The institution of Tomas Kalincik has received research support from Celgene. The institution of Tomas Kalincik has received research support from Merck. The institution of Tomas Kalincik has received research support from MSBase Foundation. The institution of Tomas Kalincik has received research support from ARSEP and EDMUS Foundations. The institution of Tomas Kalincik has received research support from MS Research Australia. The institution of Tomas Kalincik has received research support from National Health and Medical Research Council. The institution of Tomas Kalincik has received research support from Australian Research Council. The institution of Tomas Kalincik has received research support from MS Society. The institution of Tomas Kalincik has received research support from Trish Foundation. Tomas Kalincik has a non-compensated relationship as a scientific leadership group chair with MSBase Foundation that is relevant to AAN interests or activities.
Anneke Van Der Walt No disclosure on file
Vilija Jokubaitis Vilija Jokubaitis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Vilija Jokubaitis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Vilija Jokubaitis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MedEx Learning. The institution of Vilija Jokubaitis has received research support from National Health and Medical Research Council (NHMRC) of Australia. The institution of Vilija Jokubaitis has received research support from Multiple Sclerosis Australia. The institution of Vilija Jokubaitis has received research support from F.Hoffmann La-Roche. The institution of Vilija Jokubaitis has received research support from Trish Multiple Sclerosis Foundation.
Helmut Butzkueven, MD, MBBS Dr. Butzkueven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oxford Health Policy Forum. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for MSBase . The institution of Dr. Butzkueven has received research support from NHMRC. The institution of Dr. Butzkueven has received research support from Biogen. The institution of Dr. Butzkueven has received research support from Roche. The institution of Dr. Butzkueven has received research support from Novartis.
Mastura Monif, MBBS, PhD Dr. Monif has nothing to disclose.
Marelisa Albelo Martinez, MD Dr. Albelo Martinez has nothing to disclose.
Jazmín Sotomayor Ortiz Mrs. Sotomayor Ortiz has nothing to disclose.
Jose Avila-Ornelas, MD Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squib. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Banner Pharmaceuticals.
Gishlaine Alfonso, MD, FAAN Dr. Alfonso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion .
Jerome Engel, Jr., MD, PhD, FAAN Dr. Engel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerebel. Dr. Engel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Engel has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Engel has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Steven Barris. Dr. Engel has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cutler Law Firm. Dr. Engel has received publishing royalties from a publication relating to health care. Dr. Engel has received publishing royalties from a publication relating to health care. Dr. Engel has received publishing royalties from a publication relating to health care. Dr. Engel has received publishing royalties from a publication relating to health care.
Rocío Gómez, Other Ms. Gómez has received personal compensation for serving as an employee of Roche Farma Spain, Medical Department.
Nieves Tellez Nieves Tellez has nothing to disclose.
Marta Aguado Valcarcel Marta Aguado Valcarcel has nothing to disclose.
Maria Sepúlveda No disclosure on file
Alvaro Cobo Calvo Alvaro Cobo Calvo has nothing to disclose.
Aida Orviz-García, MD Dr. Orviz-García has nothing to disclose.
Maria Diaz Sanchez Maria Diaz Sanchez has nothing to disclose.
Sabas Boyero Sabas Boyero has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Sabas Boyero has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Sabas Boyero has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Sabas Boyero has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Pablo Rebollo No disclosure on file
Jorge Maurino Jorge Maurino has received personal compensation for serving as an employee of Roche Pharma Spain, Medical Department.
Harvey S. Levin, PhD No disclosure on file
Zulfi Haneef, MD, MBBS, MRCP, FAAN Dr. Haneef has received publishing royalties from a publication relating to health care.
Wendy Tsai, MD Dr. Tsai has nothing to disclose.
Anthony Traboulsee, MD Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers.
Shannon Kolind, PhD, MSc, BSc Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Kolind has received research support from Sanofi Genzyme. The institution of Dr. Kolind has received research support from Roche. The institution of Dr. Kolind has received research support from Biogen.
Anna Combes No disclosure on file
Yasodara Priyadharsi Senthamarai Siddharthan, MBBS Dr. Senthamarai Siddharthan has nothing to disclose.
Jessica D. Lee, MD, FAAN Dr. Lee has received personal compensation for serving as an employee of 好色先生. The institution of Dr. Lee has received research support from Janssen.
Margie Campbell Margie Campbell has nothing to disclose.
Robyn Huebsch No disclosure on file
Stephanie Rubenstein No disclosure on file
Christopher Love No disclosure on file
John Demir Mr. Demir has nothing to disclose.
Jonatan Hornik, MD Dr. Hornik has nothing to disclose.
Alejandro Hornik, MD Dr. Hornik has nothing to disclose.
Ashmeet S. Sahni, MD Dr. Sahni has nothing to disclose.
Andrea Loggini, MD, MPH MBA Dr. Loggini has nothing to disclose.
Mohammed Qussay Ali Al-Sabbagh, MD Dr. Al-Sabbagh has nothing to disclose.
Hussein Alsadi Hussein Alsadi has nothing to disclose.
Prasanna Venkatesan Eswaradass, MD Dr. Eswaradass has nothing to disclose.
Andres Gudino Mr. Gudino has nothing to disclose.
Arshaq Saleem The institution of Mr. Saleem has received research support from National Institutes of Health.
Sricharan Veeturi No disclosure on file
Diego Ojeda No disclosure on file
Elena Sagues, MD Ms. Sagues has nothing to disclose.
Sebastian Sanchez No disclosure on file
Fausto Dier Melo Fausto Dier Melo has nothing to disclose.
Samantha Saenz Hinojosa No disclosure on file
Ariel Vargas No disclosure on file
Edgar Samaniego, MD, FAAN Dr. Samaniego has received personal compensation for serving as an employee of University of Iowa. Dr. Samaniego has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Terumo Neuro. Dr. Samaniego has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Rapid Medical. Dr. Samaniego has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for J&J Neuro. Dr. Samaniego has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Metronic. Dr. Samaniego has received personal compensation in the range of $0-$499 for serving as a Consultant for iSchemaView. Dr. Samaniego has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Society of Neurointerventional Surgery. Dr. Samaniego has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neurointerventional Surgery.
Albert Saiz Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janseen. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for novartis. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Sheharyar Baig Dr. Baig has received research support from Association of British Neurologists (The Stroke Association and The Berkeley Foundation).
Ali Alhashimi No disclosure on file
Ryta Kamarova No disclosure on file
Krishnan Nair No disclosure on file
Jessica Redgrave No disclosure on file
Arshad Majid, MD Dr. Majid has received publishing royalties from a publication relating to health care.
Ali Ali No disclosure on file
Himanshu A. Patel, MD Dr. Patel has nothing to disclose.
Keyvan Heshmati, MD Dr. Heshmati has nothing to disclose.
Kathleen Ryan No disclosure on file
Karen Yarbrough No disclosure on file
Lakeisha Mixon No disclosure on file
Devin Williams No disclosure on file
Steven J. Kittner, MD, MPH The institution of Dr. Kittner has received research support from NINDS.
Carolyn Cronin, MD, PhD, FAAN Dr. Cronin has nothing to disclose.
Pablo Villoslada, MD, PhD, FAAN Dr. Villoslada has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oculis. Dr. Villoslada has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bionure. Dr. Villoslada has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telara Therapeutics. Dr. Villoslada has or had stock in Attune Neurosciences.Dr. Villoslada has or had stock in Bionure Therapeutics.Dr. Villoslada has or had stock in Spiral Therapeutics.Dr. Villoslada has or had stock in Adhera Health.Dr. Villoslada has or had stock in Clarity technologies.Dr. Villoslada has or had stock in QMENTA Inc. The institution of Dr. Villoslada has received research support from Start2Cure Foundation. The institution of Dr. Villoslada has received research support from European Commission. The institution of Dr. Villoslada has received research support from Instituto Salud Carlos III. The institution of Dr. Villoslada has received research support from Focused Ultrasound Foundation and ALS Foundation. The institution of Dr. Villoslada has received research support from Caixa Foundation. Dr. Villoslada has received intellectual property interests from a discovery or technology relating to health care.
Justin Vranic No disclosure on file
Amine Mohamed Marc Awad, BM BCh Dr. Awad has nothing to disclose.
James Rabinov James Rabinov has nothing to disclose.
Robert W. Regenhardt, MD, PhD Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genomadix. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapid Medical. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Johnson and Bell Trial Lawyers. Dr. Regenhardt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Buckley, Theroux, Kline, & Cooley Trial Lawyers. The institution of Dr. Regenhardt has received research support from National Institutes of Health. The institution of Dr. Regenhardt has received research support from Society of Vascular and Interventional Neurology. The institution of Dr. Regenhardt has received research support from Heitman Foundation.
Neeta S. Duggal, MD No disclosure on file
Julia Zabinska Ms. Zabinska has nothing to disclose.
Vineetha Yadlapalli Miss Yadlapalli has nothing to disclose.
Mercy H. Mazurek Miss Mazurek has nothing to disclose.
Nethra Parasuram No disclosure on file
Dheeraj D. Lalwani Mr. Lalwani has nothing to disclose.
Emma S. Peasley Miss Peasley has nothing to disclose.
Emily J. Gilmore, MD Dr. Gilmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for carpl.ai. Dr. Gilmore has received personal compensation in the range of $0-$499 for serving as a Consultant for AAN. Dr. Gilmore has received research support from NIH.
Jennifer A. Kim, MD Dr. Kim has nothing to disclose.
Sacit Bulent Omay Sacit Bulent Omay has nothing to disclose.
Gordon Sze Gordon Sze has nothing to disclose.
Sam Payabvash Sam Payabvash has nothing to disclose.
Annabel Sorby-Adams Annabel Sorby-Adams has nothing to disclose.
Jua Iglesias Gonzalez Jua Iglesias Gonzalez has nothing to disclose.
Matthew Rosen Matthew Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DeepSpin. Matthew Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chipiron. Matthew Rosen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Synex Medical. Matthew Rosen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nanalysis. Matthew Rosen has stock in Hyperfine. Matthew Rosen has stock in Q Bio. Matthew Rosen has stock in Vizma Life Sciences. Matthew Rosen has stock in Intact Data Services. The institution of Matthew Rosen has received research support from Imagion. Matthew Rosen has received intellectual property interests from a discovery or technology relating to health care.
W. T. Kimberly, MD, PhD Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrocyte Pharmaceuticals. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acasti Pharma. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Kimberly has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics. Dr. Kimberly has stock in Woolsey Pharmaceuticals. Dr. Kimberly has stock in Acasti Pharma. The institution of Dr. Kimberly has received research support from NIH. The institution of Dr. Kimberly has received research support from Hyperfine, Inc.. The institution of Dr. Kimberly has received research support from Alzheimer's Association. Dr. Kimberly has received intellectual property interests from a discovery or technology relating to health care.
Kevin N. Sheth, MD, FAAN Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Trenton M. Myers, MD No disclosure on file
Ariyaporn Haripottawekul Miss Haripottawekul has nothing to disclose.
Kareem Joudi Mr. Joudi has nothing to disclose.
Karen L. Furie, MD The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. Dr. Furie has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS.
Ali Mahta, MD Dr. Mahta has received research support from Brown University Health.
James E. Kim, MD No disclosure on file
Sigmund Lilian, MD Dr. Lilian has nothing to disclose.
Mary Carter Denny, MD Dr. Denny has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott Laboratory. The institution of Dr. Denny has received research support from NIDDILIR. Dr. Denny has received publishing royalties from a publication relating to health care.
Lowell Satler No disclosure on file
Thomas MacGillivray No disclosure on file
Iftekhar Ahmed, MD, PC, FAAN Dr. Ahmed has nothing to disclose.
Brandon May, MD Dr. May has nothing to disclose.
Michael F. Waters, MD, PhD, FAAN Dr. Waters has nothing to disclose.
Vijendra Swarup No disclosure on file
Hursh Naik No disclosure on file
Daniel Gonzalez, MD Dr. Gonzalez has nothing to disclose.
Supreet Kaur, MD Dr. Kaur has nothing to disclose.
Lynn S. Ashby, MD Dr. Ashby has nothing to disclose.
Patricia Teran Patricia Teran has nothing to disclose.
Tracie Schroeder Tracie Schroeder has nothing to disclose.
Tiffany Sheehan No disclosure on file
Emily Mawk No disclosure on file
David Z. Wang, DO, FAHA, FAAN Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Mediwelcome.
Ira R. Casson, MD Dr. Casson has nothing to disclose.
Nicholas Liquigli, DO Dr. Liquigli has nothing to disclose.
Taylor R. Anderson, MD Dr. Anderson has nothing to disclose.
Lauren Turner, DO Dr. Turner has nothing to disclose.
Christopher M. Goshgarian, MD Dr. Goshgarian has nothing to disclose.
Baljit Deol No disclosure on file
Muhammad Farooq, MD Dr. Farooq has nothing to disclose.
Ali Emami Mr. Emami has nothing to disclose.
Sepideh Paybast No disclosure on file
Mohammed K. Badi, MD Dr. Badi has nothing to disclose.
Bhrugun Anisetti, MBBS Dr. Anisetti has nothing to disclose.
Esraa S. Elsayed Miss Elsayed has nothing to disclose.
Michelle P. Lin, CRC Dr. Lin has nothing to disclose.
Md Manjurul Islam Shourav, MBBS Mr. Shourav has nothing to disclose.
Amra Sakusic, MD Dr. Sakusic has nothing to disclose.
Natalia Ramirez Rodriguez Ms. Ramirez Rodriguez has nothing to disclose.
Camilo Romero No disclosure on file
Asmaa Z. Zakria Dr. Zakria has nothing to disclose.
Yongyao Kong, MBBS Dr. Kong has nothing to disclose.
Hoe Chin Chua, MD No disclosure on file
Sithmi M. Jayasundara Miss Jayasundara has nothing to disclose.
Rachel S. Choi Ms. Choi has nothing to disclose.
Amedeo Rapuano Amedeo Rapuano has nothing to disclose.
Erin Barnes, MD An immediate family member of Dr. Barnes has received personal compensation for serving as an employee of Go2For Lung Cancer. The institution of Dr. Barnes has received research support from NIH.
Melvin Parasram, DO Dr. Parasram has nothing to disclose.
Michele Moura No disclosure on file
Puneet Uppal No disclosure on file
Yilun Chen Ms. Chen has nothing to disclose.
Ilayda Top Ms. Top has nothing to disclose.
Madelynne Olexa Miss Olexa has nothing to disclose.
Rafael Maarek Mr. Maarek has received research support from National Heart Lung & Blood Institute. Mr. Maarek has received research support from Richard K. Gershon Endowed Medical Student Research Fellowship.
Jennifer Yan No disclosure on file
Rachel Beekman, MD Dr. Beekman has nothing to disclose.
Jessica Magid-Bernstein, MD, PhD Dr. Magid-Bernstein has nothing to disclose.
Ryan Hebert Ryan Hebert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus .
Farhad Bahrassa Farhad Bahrassa has nothing to disclose.
Charles Matouk Charles Matouk has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Silk Road Medical. Charles Matouk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention. Charles Matouk has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Navigantis.
Nils Petersen, MD, FAAN The institution of Dr. Petersen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Silkroad Medical. Dr. Petersen has received research support from NIH.
Rocio C. Garcia Santibanez, MD, FAAN Dr. Garcia Santibanez has nothing to disclose.
Jiaying Zhang, MD Dr. Zhang has nothing to disclose.
David Koren, MD, PhD Dr. Koren has nothing to disclose.
Stephen N. Scelsa, MD No disclosure on file
Abdalla Albanna, MBBS Dr. Albanna has nothing to disclose.
Ammar A. Jumah, MD Dr. Jumah has nothing to disclose.
Michael Fana, MD Mr. Fana has nothing to disclose.
Momina Qureshi Miss Qureshi has nothing to disclose.
Utkarsh Agarwal, MBBS Dr. Agarwal has nothing to disclose.
Daniel Miller, MD Dr. Miller has nothing to disclose.
Thanya Lagos Thanya Lagos has nothing to disclose.
Gabriel Bravo No disclosure on file
Yojan Ceballos-Grijalba No disclosure on file
Monica Pantoja No disclosure on file
Jorge Mora Reinel No disclosure on file
Angela Catalina Vallejo Cajigas, MD Dr. Vallejo Cajigas has nothing to disclose.
Sebastian Rosero Noguera No disclosure on file
Andres Ricaurte, MD Dr. Ricaurte has nothing to disclose.
Nabil Altememi, MD No disclosure on file
Mostafa El Din Moawad Mostafa El Din Moawad has nothing to disclose.
Ibraheem Alkhawaldeh Ibraheem Alkhawaldeh has nothing to disclose.
Abdulrahman Sharaf No disclosure on file
Sumaya Alsalah No disclosure on file
Mohamed Smail Aissani No disclosure on file
Mona Elsakka Mona Elsakka has nothing to disclose.
Ibrahim Serag No disclosure on file
Osama Bisht No disclosure on file
Ahmed Negida, MD, PhD Dr. Negida has nothing to disclose.
Lauri S. Soinne, MD, PhD, FAAN Dr. Soinne has nothing to disclose.
Suvi Koskinen No disclosure on file
Petra Ijas, MD Petra Ijas, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen.
Krista Nuotio Krista Nuotio has nothing to disclose.
Pirkka Vikatmaa No disclosure on file
Perttu J. Lindsberg, MD The institution of Dr. Lindsberg has received research support from Helsinki University Hospital District. The institution of Dr. Lindsberg has received research support from Sigrid Juselius foundation.
Hai Chen, MD, PhD Dr. Chen has nothing to disclose.
Steven Levine, MD, FAHA Dr. Levine has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Law Firms. The institution of Dr. Levine has received research support from NIH.
Yohannes S. Mulatu, MD Dr. Mulatu has nothing to disclose.
Tyler Spohr, MD Mr. Spohr has nothing to disclose.
Srinath Ramaswamy, MD Dr. Ramaswamy has nothing to disclose.
Mohamed M. Eldokmak, MD Dr. Eldokmak has nothing to disclose.
Vinay Lakki, MBBS Dr. Lakki has nothing to disclose.
Abhishek Singh, MD Dr. Singh has nothing to disclose.
Himanshu Verma, MBBS Dr. Verma has nothing to disclose.
Mittal S. Prajapati, MD Dr. Prajapati has nothing to disclose.
Hizir Ulvi, MD No disclosure on file
Lucas Rios Rocha, MD Dr. Rios Rocha has nothing to disclose.
Marcelo Rocha, MD, PhD The institution of Dr. Rocha has received research support from NIH.
Mohamed Fahmy Doheim Mr. Doheim has nothing to disclose.
Raul G. Nogueira, MD Dr. Nogueira has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for for advisory roles with Anaconda, Biogen, Cerenovus, Genentech, Hybernia, Imperative Care, Medtronic, Phenox, Philips, Prolong Pharmaceuticals, Stryker Neurovascular, Shanghai Wallaby, and Synchron (consulting fees) as well as for advisory roles with Astrocyte, Brainomix, Cerebrotech, Ceretrieve, Corindus Vascular Robotics, Vesalio, Viz-AI, RapidPulse and Perfuze ( stock options). Dr. Nogueira has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firms. Dr. Nogueira has received stock or an ownership interest from Viz-AI, Perfuze, Cerebrotech, Reist/Q'Apel Medical, Truvic, and Viseon. The institution of Dr. Nogueira has received research support from Cerenovus.
Mohammad N. Kayyali, MD Dr. Kayyali has nothing to disclose.
Jay H. Bauman, PharmD No disclosure on file
Supurna Ghosh, PhD Dr. Ghosh has received personal compensation for serving as an employee of Revalesio Corporation.
Jordan S. Dubow, MD Dr. Dubow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revalesio .
Jocelyn Sutherland Jocelyn Sutherland has received personal compensation for serving as an employee of Revalesio.
Andreas Kalmes, PhD Dr. Kalmes has received personal compensation for serving as an employee of Revalesio.
Grayson Baird No disclosure on file
Jarrad Mock Jarrad Mock has received personal compensation for serving as an employee of Revalesio.
Wendy Smith Wendy Smith has nothing to disclose.
Douglas Cook Douglas Cook has nothing to disclose.
Tracy E Madsen No disclosure on file
Mahesh Jayaraman No disclosure on file
Krisztina Moldovan Krisztina Moldovan has nothing to disclose.
Radmehr Torabi Radmehr Torabi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Silk Road Medical.
Sameer Ansari Sameer Ansari has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Hyperfine. Sameer Ansari has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Sameer Ansari has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Sameer Ansari has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIcrovention. Sameer Ansari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Imperative Care. Sameer Ansari has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oculus Imaging. Sameer Ansari has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Perfuze. Sameer Ansari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapid Medical. Sameer Ansari has or had stock in Clearvoya LLC. An immediate family member of Sameer Ansari has or had stock in Hyperfine. The institution of Sameer Ansari has received research support from NIH. Sameer Ansari has received intellectual property interests from a discovery or technology relating to health care.
Christopher G. Favilla, MD The institution of Dr. Favilla has received research support from National Institutes of Health. The institution of Dr. Favilla has received research support from American Heart Association. The institution of Dr. Favilla has received research support from OpenWater, Inc..
David Chiu, MD Dr. Chiu has nothing to disclose.
Wayne M. Clark, MD Dr. Clark has nothing to disclose.
David S. Liebeskind, MD, FAAN Dr. Liebeskind has received research support from Cerenovus. Dr. Liebeskind has received research support from Genentech . Dr. Liebeskind has received research support from Medtronic. Dr. Liebeskind has received research support from Stryker.
Ryan A McTaggart No disclosure on file
Mona Bahouth, MD, PhD, FAAN The institution of Dr. Bahouth has received research support from NIH.
Nicholas Bascou, MD Nicholas Bascou has nothing to disclose.
Susanne Gonzalez, MD No disclosure on file
Sayed Mustafa M. Shah, MBBS Dr. Shah has nothing to disclose.
Maheen Kalwar, MBBS Dr. Kalwar has nothing to disclose.
Umer U. Malik Mr. Malik has nothing to disclose.
Eisha Tur. Raazia Eisha Tur. Raazia has nothing to disclose.
Midori Memon No disclosure on file
Rabia Zafar No disclosure on file
Afrah Hassan No disclosure on file
Osama Muhammad Alam No disclosure on file
Sanjana Rani No disclosure on file
Aiman Qureshi No disclosure on file
Nicholas Mathenia, DO No disclosure on file
Maryam Zulfiqar, MD Dr. Zulfiqar has nothing to disclose.
Kyle Distler Mr. Distler has nothing to disclose.
Parneet K. Grewal, MD The institution of Dr. Grewal has received research support from Bristol Myer Squibb Foundation. The institution of Dr. Grewal has received research support from IPSEN Global.
Chirantan Banerjee, MD, MPH Dr. Banerjee has nothing to disclose.
Sanjay Pandey, MD Dr. Pandey has nothing to disclose.
Alexander Zhao Mr. Zhao has nothing to disclose.
Zachary Grinspan, MD Dr. Grinspan has received personal compensation for serving as an employee of Weill Cornell Medicine. Dr. Grinspan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpha Insights. Dr. Grinspan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharma LTD (South Korea). Dr. Grinspan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Encoded Therapeutics. The institution of Dr. Grinspan has received research support from SLC6A1 Connect. The institution of Dr. Grinspan has received research support from STXBP1 Foundation. The institution of Dr. Grinspan has received research support from Clara Inspired. The institution of Dr. Grinspan has received research support from Amgen. The institution of Dr. Grinspan has received research support from NINDS. Dr. Grinspan has received intellectual property interests from a discovery or technology relating to health care.
Natasha Basma No disclosure on file
Sarah Chowdhury Miss Chowdhury has nothing to disclose.
Carson Gundlach No disclosure on file
Ashwin Mahesh No disclosure on file
Nuran Golbasi No disclosure on file
Xiaofan Huang No disclosure on file
Sujal Manohar, MD Dr. Manohar has nothing to disclose.
Ellen Fremion No disclosure on file
Jonathan Castillo No disclosure on file
Heidi Castillo No disclosure on file
Kristen Staggers No disclosure on file
Robert Hoepner Robert Hoepner has nothing to disclose.
Meredith F. Yang Ms. Yang has nothing to disclose.
Sandi Lam No disclosure on file
Kayla Byrne No disclosure on file
Sydney A. Wing, PhD Dr. Wing has nothing to disclose.
Christopher Giza, MD, FAAN Dr. Giza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical Network Speakers Bureau. Dr. Giza has stock in Highmark Interactive. The institution of Dr. Giza has received research support from UCLA: Brain Injury Research Center, Steve Tisch BrainSPORT Program, Easton Clinic for Brain Health. Dr. Giza has received publishing royalties from a publication relating to health care. Dr. Giza has a non-compensated relationship as a Advisory Board with Major League Soccer that is relevant to AAN interests or activities. Dr. Giza has a non-compensated relationship as a Advisory Board with National Basketball Association that is relevant to AAN interests or activities. Dr. Giza has a non-compensated relationship as a Consultant with United States Soccer Federation that is relevant to AAN interests or activities. Dr. Giza has a non-compensated relationship as a Co-founder & Advisor with Symptomwise that is relevant to AAN interests or activities.
Neil A. Bhathela, MD Dr. Bhathela has nothing to disclose.
Talin Babikian Talin Babikian has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Various. The institution of Talin Babikian has received research support from NINDS.
Natalie A. Gavi, RD Ms. Gavi has nothing to disclose.
Philip Rosenbaum Mr. Rosenbaum has received research support from Region IV Training Center.
Joshua Caiquo No disclosure on file
Daniel Ignacio No disclosure on file
Bradley Barney No disclosure on file
Faustina France-Nkansah No disclosure on file
Laura Gilbert, DO, MBA Dr. Gilbert has nothing to disclose.
Bhooma R. Aravamuthan, MD, DPhil, FCNS, FAAN The institution of Dr. Aravamuthan has received research support from National Institute of Neurological Disorders and Stroke. The institution of Dr. Aravamuthan has received research support from Child Neurology Foundation. The institution of Dr. Aravamuthan has received research support from American Board of Psychiatry and Neurology. The institution of Dr. Aravamuthan has received research support from Centers for Disease Control. Dr. Aravamuthan has received publishing royalties from a publication relating to health care.
Michelle R. Christie, MD Dr. Christie has nothing to disclose.
Anthony Riccio No disclosure on file
Rusty Hartman No disclosure on file
Jacob Zide No disclosure on file
Michael O'Sullivan No disclosure on file
Sydney N. Carnes, MD Mrs. Carnes has nothing to disclose.
John L. Kearfott, MD Mr. Kearfott has nothing to disclose.
Gogi Kumar, MD Dr. Kumar has nothing to disclose.
Laura Fonseca Laura Fonseca has nothing to disclose.
Araam Abboud Ms. Abboud has nothing to disclose.
Andrew H. Chan, MD No disclosure on file
Ty Copeland No disclosure on file
Aravindhan Veerapandiyan, MD Dr. Veerapandiyan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen, Novartis,Edgewise Therapeutics, Pfizer, PTC Therapeutics, Sarepta Therapeutics, Inc., UCB Pharma, Catalyst, Entrada, Lupin, Percheron, ITF. Dr. Veerapandiyan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Veerapandiyan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Muscle and Nerve. The institution of Dr. Veerapandiyan has received research support from AMO Pharma, Capricor Therapeutics, Edgewise Therapeutics, FibroGen, Muscular Dystrophy Association, Novartis, Parent Project Muscular Dystrophy, Pfizer, RegenxBio, SolodBio and Sarepta Therapeutics. Dr. Veerapandiyan has received personal compensation in the range of $5,000-$9,999 for serving as a MD with PPMD, MDA.
Lauren Treat, MD Dr. Treat has nothing to disclose.
Rachel Schrader No disclosure on file
Ellen Wagner No disclosure on file
Matthew Anderson No disclosure on file
Neishay Ayub, MD The institution of Dr. Ayub has received research support from Brown Physicians Incorporated. The institution of Dr. Ayub has received research support from Pappitto Opportunity Connection.
Tina M. Burton, MD Dr. Burton has nothing to disclose.
Yeseon Moon No disclosure on file
Abigail E. Connor Ms. Connor has nothing to disclose.
Alvand Moini, MD Mr. Moini has nothing to disclose.
Paola Martinez, MD Dr. Martinez has nothing to disclose.
Deborah L. Carver, MD Dr. Carver has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan.
Blair Ford, MD, FAAN No disclosure on file
Richard I. Suarez, MD Mr. Suarez has nothing to disclose.
Jenny Fortun Jenny Fortun has nothing to disclose.
Sheryl R. Haut, MD Dr. Haut has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ventus. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbieVe. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Iqvia.
Brian Emmert, Jr., MD Dr. Emmert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zynx. Dr. Emmert has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Aquifer.
Grace C. Kimbaris, MD Dr. Kimbaris has nothing to disclose.
Melissa Motta, MD, MPH, FAAN Dr. Motta has nothing to disclose.
Ediel Almeida, MD Mr. Almeida has nothing to disclose.
Nicholas Fioravante, MD Dr. Fioravante has nothing to disclose.
Kent Martine Mok, MD Mr. Mok has nothing to disclose.
Megan E. Esch, MD The institution of Dr. Esch has received research support from PCORI.
Patrick Callaghan, MD Dr. Callaghan has nothing to disclose.
Neil R. Holland, MBBS, FAAN Dr. Holland has nothing to disclose.
Maryann Mays, MD, FAAN Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oakley Health. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech Medical. Dr. Mays has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. The institution of Dr. Mays has received research support from Amgen. The institution of Dr. Mays has received research support from Lundbeck.
Maya M. Ramy, MD Miss Ramy has nothing to disclose.
Tanu Garg, MD Dr. Garg has nothing to disclose.
Ryan Nguyen, MD Dr. Nguyen has nothing to disclose.
Tracey A. Milligan, MD, FAAN Dr. Milligan has received publishing royalties from a publication relating to health care.
Ahamed Subir Humyum Kabir No disclosure on file
Ian Ramsay No disclosure on file
Tiffany A. Eatz, MD Dr. Eatz has nothing to disclose.
Maxon Knott The institution of Maxon Knott has received research support from American Heart Assiciation.
Venkata Sai Manikant Sanikommu Venkata Sai Manikant Sanikommu has received personal compensation for serving as an employee of University Of Miami.
Hayes Fountain, MEd No disclosure on file
Ahmed Abdelsalam No disclosure on file
Eva Wu No disclosure on file
Robert Starke Robert Starke has nothing to disclose.
Dileep R. Yavagal, MD, FAAN Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vascular Dynamics. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. The institution of Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus/Johnson & Johnson. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Poseydon. Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Athersys. Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gravity Medical Technology. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseydon. Dr. Yavagal has stock in Poseydon. Dr. Yavagal has stock in Galaxy Therapeutics. Dr. Yavagal has stock in Stentrode. Dr. Yavagal has stock in Gravity Medical. Dr. Yavagal has stock in Gravity Medical Technology. Dr. Yavagal has stock in Athersys. Dr. Yavagal has stock in Rapid Medical . Dr. Yavagal has received intellectual property interests from a discovery or technology relating to health care. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Expert with Royal Carribean Cruise Line. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Consultant with Carnival Cruise Line.
Lorena M. Figueredo Rivas, MD Dr. Figueredo Rivas has nothing to disclose.
Leonid Gozman, MD Dr. Gozman has nothing to disclose.
Michael P. Siegel, MD Dr. Siegel has nothing to disclose.
Steven Carter, Jr., DO Dr. Carter has nothing to disclose.
Lindsey Le, DO Dr. Le has nothing to disclose.
Maria J. Bruzzone, MD, FAAN Dr. Bruzzone has nothing to disclose.
Jeffrey S. Gitt, DO No disclosure on file
Jonathan P. Williams, MD, MSCR Dr. Williams has received personal compensation in the range of $0-$499 for serving as a Consultant for Neuralis.
Ventaka Bendi, MBBS Dr. Bendi has nothing to disclose.
David Heron, MD Dr. Heron has nothing to disclose.
Rachel J. Miller, MD Dr. Miller has nothing to disclose.
Adam S. Greenblatt, MD Dr. Greenblatt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beacon Biosignals.
Fabio Nascimento, MD Dr. Nascimento has received publishing royalties from a publication relating to health care.
Julio M. Cuevas Mr. Cuevas has nothing to disclose.
Jens Watzlawik No disclosure on file
Ruta N. Yardi, MD Dr. Yardi has nothing to disclose.
Sally V. Mathias, MD, FANA, FAES, FAAN Dr. Mathias has or had stock in Abbvie Inc.Dr. Mathias has received personal compensation in the range of $100,000-$499,999 for serving as a neurologist with Department of Veterans Affairs (VHA).
Ana Maria Roman, MD Dr. Roman has nothing to disclose.
Christopher McLouth Christopher McLouth has nothing to disclose.
Lara Jehi, MD Dr. Jehi has nothing to disclose.
Rani Priyanka Vasireddy, MBBS Dr. Vasireddy has nothing to disclose.
Andrew Wood Andrew Wood has nothing to disclose.
Sandeepa Mullady, MD Dr. Mullady has nothing to disclose.
Elan Guterman, MD Dr. Guterman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Guterman has stock in REMO Health. The institution of Dr. Guterman has received research support from NIH. The institution of Dr. Guterman has received research support from AAN.
Nicole Rosendale, MD, FAAN Dr. Rosendale has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Rosendale has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Rosendale has received research support from 好色先生. The institution of Dr. Rosendale has received research support from NIH StrokeNet Fellowship. The institution of Dr. Rosendale has received research support from The Dana Foundation. The institution of Dr. Rosendale has received research support from UArizona-Banner All of Us Seed Grant. Dr. Rosendale has received publishing royalties from a publication relating to health care.
Mohammad Dastjerdi, MD Dr. Dastjerdi has nothing to disclose.
Cindy McKernan, RN Mrs. McKernan has nothing to disclose.
Rachel S. Kim Dr. Kim has nothing to disclose.
Robert Kahoud No disclosure on file
Paneeni Lohana, DO Dr. Lohana has nothing to disclose.
Heidi Munger Clary, MD, MPH Dr. Munger Clary has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xenon. Dr. Munger Clary has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prova 好色先生. Dr. Munger Clary has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia Open. Dr. Munger Clary has stock in HCA Healthcare. Dr. Munger Clary has stock in Eli Lilly. Dr. Munger Clary has stock in Procter and Gamble. Dr. Munger Clary has stock in CVS. Dr. Munger Clary has stock in Johnson and Johnson. Dr. Munger Clary has stock in Novartis. Dr. Munger Clary has stock in Danahauer. The institution of Dr. Munger Clary has received research support from National Institute of Health. The institution of Dr. Munger Clary has received research support from Suzanne Marcus Collins Foundation. The institution of Dr. Munger Clary has received research support from Eysz, Inc. The institution of Dr. Munger Clary has received research support from Department of Defense. The institution of Dr. Munger Clary has received research support from Duke Endowment. Dr. Munger Clary has received personal compensation in the range of $500-$4,999 for serving as a speaker, Psychiatry Commission member with International League Against Epilepsy. Dr. Munger Clary has received personal compensation in the range of $0-$499 for serving as a Faculty with J. Kiffin Penry Epilepsy 好色先生 Programs. Dr. Munger Clary has a non-compensated relationship as a advisor, potential site PI with Liva Nova that is relevant to AAN interests or activities.
Beverly Snively The institution of Beverly Snively has received research support from National Institutes of Health. The institution of Beverly Snively has received research support from Duke Endowment. The institution of Beverly Snively has received research support from Department of Defense. The institution of Beverly Snively has received research support from PCORI.
Jerryl Christopher No disclosure on file
Sabina Gesell No disclosure on file
Mu Cheng No disclosure on file
Andra-Ecaterina Boca No disclosure on file
Ann Dandurand No disclosure on file
Jiainbin Mao No disclosure on file
Koji Takahashi, PhD Dr. Takahashi has received personal compensation for serving as an employee of Cerevel Therapeutics. Dr. Takahashi has stock in Cerevel Therapeutics.
Churong Xu No disclosure on file
Yan Song No disclosure on file
Moses Rodriguez, MD, FAAN Dr. Rodriguez has received intellectual property interests from a discovery or technology relating to health care.
Niels V. Pacheco, MD Mr. Pacheco has nothing to disclose.
Carlos Alva-Diaz Carlos Alva-Diaz has nothing to disclose.
Andre Lapeyre Rivera Mr. Lapeyre Rivera has nothing to disclose.
Luis F. Purisaca Neira, MD Dr. Purisaca Neira has nothing to disclose.
Daniel Fernandez-Guzman No disclosure on file
Poul Espino-Alvarado No disclosure on file
John Rolston John Rolston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuropace. The institution of John Rolston has received research support from NIH. The institution of John Rolston has received research support from Raynor Foundation. The institution of John Rolston has received research support from Pediatric Epilepsy Research Foundation. The institution of John Rolston has received research support from Lennox-Gastaut Foundation.
Jorge G. Burneo, MD, MSPH, FAAN Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, Clinical Neurology and Neurosurgery Journal. Dr. Burneo has received research support from The Jack Cowin Endowed Chair in Epilepsy Research. Dr. Burneo has received publishing royalties from a publication relating to health care. Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Jazz Pharmaceuticals.
Gavin Giovannoni, MD Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Marissa Kellogg, MD, MPH, FAAN The institution of Dr. Kellogg has received research support from VA & DoD.
Megan Amuan No disclosure on file
Jacqueline Hirschey, MD Dr. Hirschey has nothing to disclose.
W. C. LaFrance, Jr., MD, MPH, FAAN Dr. LaFrance has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medico-legal work.. The institution of Dr. LaFrance has received research support from Department of Defense. Dr. LaFrance has received publishing royalties from a publication relating to health care. Dr. LaFrance has received publishing royalties from a publication relating to health care. Dr. LaFrance has a non-compensated relationship as a Steering Committee Member with Xenon that is relevant to AAN interests or activities.
Hamada H. Altalib, DO The institution of Dr. Altalib has received research support from UCB. The institution of Dr. Altalib has received research support from DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS.
Rizwana Rehman No disclosure on file
Mary Jo Pugh, PhD, RN, FAAN The institution of Dr. Pugh has received research support from Department of Defense, Epilepsy Research Program. The institution of Dr. Pugh has received research support from VA Health Services Research and Development Service. The institution of Dr. Pugh has received research support from VA Rehabilitation Research and Development Service. The institution of Dr. Pugh has received research support from Congressionally Directed Research Programs.
David H. Margolin, MD, PhD Dr. Margolin has received personal compensation for serving as an employee of uniQure, Inc.. Dr. Margolin has stock in Cerevance, Inc. Dr. Margolin has stock in Datacubed Health. Dr. Margolin has stock in uniQure, Inc.. Dr. Margolin has received intellectual property interests from a discovery or technology relating to health care.
Drishti Shah, PhD Dr. Shah has received personal compensation for serving as an employee of Takeda.
Jeffrey Andrews No disclosure on file
Arturo I. Benitez, MD Dr. Benitez has received personal compensation for serving as an employee of Takeda.
Jonathan de Courcy No disclosure on file
Yasmin Taylor Yasmin Taylor has received personal compensation for serving as an employee of Adelphi Real World.
Hannah Connolly Hannah Connolly has nothing to disclose.
Sophie Lai No disclosure on file
Vicente Villanueva Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Angelini. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport. Vicente Villanueva has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Vicente Villanueva has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Angelini. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI. Vicente Villanueva has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Paladin. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz pharmaceutical.
Paige Skorseth, MD Dr. Skorseth has nothing to disclose.
Rachael Eby, DO Dr. Eby has nothing to disclose.
Lucretia Long, DNP, APRN-CNP, FAES Mrs. Long has received personal compensation for serving as an employee of SKLife. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SKLife. Mrs. Long has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst Pharmaceutical. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Liva Nova. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK lIFE. Mrs. Long has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Liva Nova.
Sarita W. Maturu, MD Dr. Maturu has nothing to disclose.
Jennifer Graves, MD, PhD Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono.
Edward B. Lee Pan, MD Dr. Lee Pan has nothing to disclose.
Lawrence Tucker No disclosure on file
Shigeru Kaneki Mr. Kaneki has nothing to disclose.
Manisha G. Holmes, MD Dr. Holmes has nothing to disclose.
Sarah Barnard Sarah Barnard has nothing to disclose.
Jacqueline French, MD, FAAN Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Praxis. Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Acadia Pharmaceuticals Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Access Industries that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Acuta Capital Partners LLC that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with AFASCI Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Agrithera, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Alkermes that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Angelini Pharma S.p.A. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Autifony Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Axonis Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bain Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Beacon Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biogen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Bloom Science, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bright Minds Biosciences, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Capsidia Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, SAB with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ceribell that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cowen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with EcoR1 Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EG 427 that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, Advisory Board with Eisai that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant/Advisory Board with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EpiMinder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Harmony that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Ionis Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with IQVIA that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Janssen Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Jazz Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, with Livanova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with London Research & Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Longboard Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Maplight Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Medscape/Web MD that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Montara Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Mosaica Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neumarker that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neurelis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neuropace that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neuroventis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neurona Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Neuvarti that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Noema that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ono Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Otsuka that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Ovid Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LYT Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with QurAlis Corp that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Receptor Holdings, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rivervest Venture Partners that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Sage Therapeutics, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with SK Life Science that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stream Neuroscience that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Taysha Gene Therapies that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with UCB, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with uniQure that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Xenon Pharmaceuticals that is relevant to AAN interests or activities.
Daniel H. Lowenstein, MD Dr. Lowenstein has received research support from NIH.
Kwee L. Thio, MD The institution of Dr. Thio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Thio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epilepsy Study Consortium. The institution of Dr. Thio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals. The institution of Dr. Thio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ovid Therapeutics. The institution of Dr. Thio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda Pharmaceuticals. The institution of Dr. Thio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zogenix. The institution of Dr. Thio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Marinus Pharmaceuticals. The institution of Dr. Thio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Biopharmaceuticals. The institution of Dr. Thio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. The institution of Dr. Thio has received research support from NIH. The institution of Dr. Thio has received research support from Siteman Cancer Center - Washington University, Barnes-Jewish Hospital. The institution of Dr. Thio has received research support from Epilepsy Study Consortium. The institution of Dr. Thio has received research support from St. Louis Children's Hospital Foundation. Dr. Thio has received intellectual property interests from a discovery or technology relating to health care.
Ruben I. Kuzniecky, MD, FAAN Dr. Kuzniecky has nothing to disclose.
Ahmed M. Yassin, MD Dr. Yassin has nothing to disclose.
Ethar Hazaimeh, MD Dr. Hazaimeh has nothing to disclose.
Zaid S. Miqdadi Mr. Miqdadi has nothing to disclose.
Sebawe Syaj No disclosure on file
Salma Bashayreh, MD Dr. Bashayreh has nothing to disclose.
Khalid El-Salim No disclosure on file
Yasmeen Al-abdallat Yasmeen Al-abdallat has nothing to disclose.
Abdallah I. AlHusan Mr. AlHusan has nothing to disclose.
Maria Burbano No disclosure on file
Lucia Belen Varela Lucia Belen Varela has nothing to disclose.
Carlos Andres Mateos No disclosure on file
Yandri Garcia Fernandez No disclosure on file
Francisco Abril, MD Dr. Abril has nothing to disclose.
Juan Carlos Avalos No disclosure on file
Gabriela Besocke No disclosure on file
Barbara Rosso No disclosure on file
Walter H. Silva Walter H. Silva has nothing to disclose.
Silvia Christiansen No disclosure on file
Carlos Ciraolo No disclosure on file
Maria del Carmen Garcia No disclosure on file
Mario Minor Murakami, Jr., MD Dr. Murakami has nothing to disclose.
Carl Trolle No disclosure on file
Diana Tran No disclosure on file
Brit Seipp No disclosure on file
Clas Linnman No disclosure on file
Nguyen Nguyen No disclosure on file
Ricardo Battaglino No disclosure on file
Leslie Morse No disclosure on file
Umang M. Shah, MD No disclosure on file
Alyssa Nylander, MD, PhD Dr. Nylander has nothing to disclose.
Kyra Henderson Kyra Henderson has nothing to disclose.
Kanishka Koshal No disclosure on file
Nikki Sisodia Nikki Sisodia has nothing to disclose.
Shane Poole Shane Poole has nothing to disclose.
Jim Rowson No disclosure on file
Cathra Halabi, MD The institution of Dr. Halabi has received research support from UC Noyce Initiative. The institution of Dr. Halabi has received research support from Weill Institute for Neurosciences Neurohub. The institution of Dr. Halabi has received research support from NIH/NIDCD. The institution of Dr. Halabi has received research support from NIH/StrokeNet. Dr. Halabi has a non-compensated relationship as a Working Group Member with National Academies of Sciences, Engineering, and Medicine Action Collaborative on TBI Care that is relevant to AAN interests or activities. Dr. Halabi has a non-compensated relationship as a Working Group Member with NIH/StrokeNet Recovery and Rehabilitation Working Group that is relevant to AAN interests or activities.
Jill L. Ostrem, MD, FAAN Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz . Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Superness. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AcureX. Dr. Ostrem has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspen. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders. The institution of Dr. Ostrem has received research support from Neuroderm. The institution of Dr. Ostrem has received research support from Boston Scientific. The institution of Dr. Ostrem has received research support from Medtronic. The institution of Dr. Ostrem has received research support from Rune.
Simon Little Simon Little has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Iota Biosciences.
Ethan G. Brown, MD Dr. Brown has received personal compensation in the range of $0-$499 for serving as a Consultant for Rune Labs, Inc. An immediate family member of Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Brown has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint Inc. An immediate family member of Dr. Brown has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brown has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Knowledge Plus. Dr. Brown has stock in 153 Therapeutics. The institution of Dr. Brown has received research support from Michael J. Fox Foundation. The institution of Dr. Brown has received research support from NIH.
Adam Staffaroni Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Adam Staffaroni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Aviado Bio. Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CervoMed. Adam Staffaroni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Prevail Therepeutics/Eli Lilly. Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. The institution of Adam Staffaroni has received research support from NIH. The institution of Adam Staffaroni has received research support from Bluefield Project To Cure FTD. The institution of Adam Staffaroni has received research support from AFTD/ALSA. Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Scientific Advisory Board member with AADF.
Yuriy Zeylikman, MD No disclosure on file
Shaumprovo Debnath No disclosure on file
Umer Akbar, MD Dr. Akbar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LANGaware.
Austin Flitton No disclosure on file
Michael Ferguson Michael Ferguson has nothing to disclose.
Jared A. Nielsen, PhD Prof. Nielsen has nothing to disclose.
Frederic Schaper, MD, PhD Dr. Schaper has nothing to disclose.
Elijah Baughan No disclosure on file
Evren Burakgazi, MD Dr. Burakgazi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK life Sciences. Dr. Burakgazi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis.
Ram Kinker Mishra, PhD Dr. Mishra has received personal compensation for serving as an employee of BioSensics LLC.
Mansi Sharma Miss Sharma has nothing to disclose.
Jose Casado Jose Casado has received personal compensation for serving as an employee of Biosensics.
Adonay Nunes Adonay Nunes has nothing to disclose.
Ashkan Vaziri, PhD Dr. Vaziri has received personal compensation for serving as an employee of Biosensics.
Alexander Pantelyat, MD, FAAN Dr. Pantelyat has received personal compensation for serving as an employee of MedRhythms, Inc.. Dr. Pantelyat has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedRhythms, Inc.. Dr. Pantelyat has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Kelly & Ignoffo Law Group. The institution of Dr. Pantelyat has received research support from NIH/NIA.
Anne Marie A. Wills, MD Dr. Wills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant, a CVS/Caremark company. Dr. Wills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi/Genzyme. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharmaceuticals. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Wills has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson's Foundation. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx Pharmaceuticals. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharmaceuticals. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Wills has received research support from Parkinson's Foundation. The institution of Dr. Wills has received research support from Biogen. The institution of Dr. Wills has received research support from Roche/Genentech. The institution of Dr. Wills has received research support from BioSensics.
AJ Hall AJ Hall has nothing to disclose.
Melissa A. Carran, MD Dr. Carran has nothing to disclose.
Raphael Bertani Raphael Bertani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brain4care .
Savio Batista, MD Mr. Batista has nothing to disclose.
Leonardo Oliveira Leonardo Oliveira has nothing to disclose.
Lucca Palavani No disclosure on file
Marcelo E. Bigal, MD, PhD No disclosure on file
David Y. Chung, MD The institution of Dr. Chung has received research support from NIH/NINDS. The institution of Dr. Chung has received research support from Brain Aneurysm Foundation. The institution of Dr. Chung has received research support from Angea Biotherapeutics.
Cenk Ayata, MD Dr. Ayata has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quris. Dr. Ayata has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. The institution of Dr. Ayata has received research support from NIH. The institution of Dr. Ayata has received research support from Takeda. The institution of Dr. Ayata has received research support from Neurelis.
Brian Edlow, MD Dr. Edlow has received research support from NIH.
Miran Oncel, MD Mr. Oncel has nothing to disclose.
James H. Lai Mr. Lai has nothing to disclose.
Jian Li No disclosure on file
Sanem Aykan No disclosure on file
Andrea Harriott, MD Dr. Harriott has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Harriott has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of New England. The institution of Dr. Harriott has received research support from Electrocore. Dr. Harriott has a non-compensated relationship as a Author agreement with Abbvie that is relevant to AAN interests or activities. Dr. Harriott has a non-compensated relationship as a Researcher/Receipt of drug with Praxis that is relevant to AAN interests or activities.
David Boas No disclosure on file
Joanna Yang No disclosure on file
Sava Sakadzic No disclosure on file
Tao Qin No disclosure on file
Mazzy F. Marcucci No disclosure on file
Keaton C. Helquist No disclosure on file
Owen Benzley No disclosure on file
Michele D. Bronson, PhD No disclosure on file
Saurabh Garg No disclosure on file
Sam Hashemi Mr. Hashemi has received personal compensation for serving as an employee of Prenuvo.
Raj Attariwala, MD, PhD Dr. Attariwala has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Prenuvo. Dr. Attariwala has stock in Prenuvo. Dr. Attariwala has received research support from Voxelwise Imaging Technology. Dr. Attariwala has received personal compensation in the range of $100,000-$499,999 for serving as a Radiologist reading cases and helping build in house software tools with Prenuvo.
Nasrin Akbari No disclosure on file
Madhurima Datta No disclosure on file
Soojin Lee No disclosure on file
Thanh Nguyen No disclosure on file
Arun Rajendran No disclosure on file
Yosef Chodakiewitz No disclosure on file
Jorge Cervantes Mr. Cervantes has nothing to disclose.
Shirin Jamal Omidi, MD Dr. Jamal Omidi has nothing to disclose.
Rodrigo Hasbun Rodrigo Hasbun has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biomeriaux. The institution of Rodrigo Hasbun has received research support from Biomeriaux.
Rajesh K. Gupta, MBBS Dr. Gupta has nothing to disclose.
Rafael Escandon No disclosure on file
Ana Morales No disclosure on file
John Garcia No disclosure on file
Tali Ekstein No disclosure on file
Catherine Schlechter No disclosure on file
Jasmine Patanapirom No disclosure on file
Tanya Bardakjian Tanya Bardakjian has received personal compensation for serving as an employee of sarepta Therapeutics. Tanya Bardakjian has stock in Sarepta.
Erin O'Rourke No disclosure on file
Andrew Y. Robinson, MD No disclosure on file
Yunting Yu, MD Miss Yu has nothing to disclose.
Nader Dahdaleh No disclosure on file
Sachin Govind Mr. Govind has nothing to disclose.
Patrick M. Grogan, MD, FAAN No disclosure on file
Lincey A. Wilson, MD Dr. Wilson has nothing to disclose.
Jacob Ralston No disclosure on file
Anna Zukowski No disclosure on file
Duaa Dakhlallah No disclosure on file
Kate Karelina No disclosure on file
Muhammad M. Alvi, MD, FAAN Dr. Alvi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brainomix.
Candice Brown No disclosure on file
Pedro Lylyk No disclosure on file
Adnan Siddiqui Adnan Siddiqui has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott Laboratories, Acandis, Asahi Intecc Co. Ltd., Canon Medical Systems USA, Inc., Carotix Medical, LLC, CerebrovaKP, Cerenovus, Contego Medical, Inc., Cordis, Endostream Medical, Ltd (recently sold to Kaneka), FreeOx Biotech, SL, Hyperfine Operations, Inc., Imperative Care , InspireMD, Ltd., IRRAS AB, Medtronic, Minnetronix Neuro, Inc., MMI, Peijia Medical, Penumbra, Inc. Perflow Medical, Ltd., Piraeus Medical, Inc., Prometheus Therapeutics, Inc., Q'Apel Medical, Inc., Serenity Medical, Inc., Shockwave Medical, Inc., Stryker Neurovascular., Synchron Australia Pty Ltd., Tegus Medical, GmbH, T.G. Medical, Inc., Terumo Neuro (Formerly MicroVention), Unity Medical, Inc. Vastrax, LLC, Vesalio, Viz.ai, Inc., WL Gore. Adnan Siddiqui has stock in 3N Endovascular, Adona Medical, Inc., Basecamp Vascular SAS, Bend IT Technologies, Ltd., BlinkTBI, Inc, Borvo Medical, Inc., CerebrovaKP, Code Zero Medical, Inc., Cognition Medical, Collavidence, Inc., Contego Medical, Inc., CVAID Ltd., CygnusMed, E8, Inc., Endostream Medical, Ltd (Sold 2025 to Kaneka), FreeOx Biotech, SL, Galaxy Therapeutics, Inc., Hyperion Surgical, Inc., Imperative Care, Inc., InspireMD, Ltd., Instylla, Inc., IRRAS, AB, Launch NY, Inc., Neurolutions, Inc., Neurovascular Diagnostics, Inc., NeXtGen Biologics, Peijia Medical, PerFlow Medical, Ltd., Physician X, LLC, Piraeus Medical, Inc., Prometheus Therapeutics, Inc., PUMA Venture Capital Fund I, LP, Q'Apel Medical, Inc., QAS.ai, Inc., Radical Catheter Technologies, Inc., ReNiva, Inc., Rist Neurovascular, Inc. (Purchased 2020 by Medtronic), Sense Diagnostics, Inc., Serenity Medical, Inc., Silk Road Medical, Sim & Cure, Spinnaker Medical, Inc., Stent'Up, Synchron, Inc., Tegus Medical, GmbH, T.G. Medical, Inc., Tulavi Therapeutics, Inc., Vastrax, LLC,, Viseon, Inc., Viz.ai, Whisper Medical, Inc., Willow Medtech, Inc. . Adnan Siddiqui has received research support from National PI/Steering Committees: Cerenovus EXCELLENT and ARISE II Trial; Medtronic ARTISSE IDE, SWIFT PRIME, VANTAGE, EMBOLISE and SWIFT DIRECT Trials; Terumo Neuro (formerly MicroVention) FRED Trial & CONFIDENCE Study; MUSC POSITIVE Trial; Penumbra 3D Separator Trial, COMPASS Trial, INVEST Trial, MIVI neuroscience EVAQ Trial; Rapid Medical SUCCESS Trial; InspireMD C-GUARDIANS IDE Pivotal Trial; . The institution of Adnan Siddiqui has received research support from Current Research Grants: Co-I for NSF 2304388 STTR Phase II: An AI-Enhanced Angiographic System to Guide Endovascular Treatment of Intracranial Aneurysms; Co-PI NIH OT2NS129366 / Medical University of South Carolina StrokeNet Thrombectomy Endovascular Platform (STEP); PI for Brain Aneurysm Foundation study titled Exploring the Relationship between Imaging- and Blood-Based Aneurysm Biomarkers and the Pathobiology of the Aneurysm Wall; PI for University of Cincinnati / NINDS FASTEST: rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time Trial;. Adnan Siddiqui has received intellectual property interests from a discovery or technology relating to health care.
Howard Riina No disclosure on file
Ivan Lylyk No disclosure on file
Carlos Bleise No disclosure on file
Esteban Scrivano No disclosure on file
Joseph Antonios No disclosure on file
Brandon Beneduce No disclosure on file
Elad Levy No disclosure on file
Carl Heilman No disclosure on file
Adel Malek, MD, PhD Prof. Malek has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for CereVasc Inc.. Prof. Malek has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerus Endovascular/Stryker. Prof. Malek has stock in CereVasc Inc.. Prof. Malek has received intellectual property interests from a discovery or technology relating to health care.
Jenny P. Tsai, MD No disclosure on file
Sanjula D. Singh, MD, PhD Dr. Singh has nothing to disclose.
Cyprien Rivier, MD Dr. Rivier has nothing to disclose.
Tin Oreskovic No disclosure on file
Sinclair Carr No disclosure on file
Keren Papier No disclosure on file
Zeina N. Chemali, MD Dr. Chemali has nothing to disclose.
Leidys Gutierrez-Martinez, MD The institution of Dr. Gutierrez-Martinez has received research support from American Heart Association.
Akashleena Mallick, MD, MBBS Dr. Mallick has nothing to disclose.
Livia Parodi No disclosure on file
Ernst Mayerhofer, MD Dr. Mayerhofer has nothing to disclose.
Jasper R. Senff, MD Dr. Senff has nothing to disclose.
Christina Kourkoulis No disclosure on file
Sandro Marini, MD Dr. Marini has nothing to disclose.
Santiago Clocchiatti-Tuozzo Mr. Clocchiatti-Tuozzo has nothing to disclose.
Courtney Nunley No disclosure on file
Amy Newhouse No disclosure on file
An Ouyang No disclosure on file
Ronald M. Lazar, PhD, FAHA, FAAN, FAAN Dr. Lazar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DiaMedica Therapeutics Inc. . The institution of Dr. Lazar has received research support from National Institutes of Health. Dr. Lazar has received publishing royalties from a publication relating to health care.
Aleksandra Pikula, MD The institution of Dr. Pikula has received research support from CIHR.
Sarah Ibrahim No disclosure on file
Bart Brouwers No disclosure on file
Virginia J. Howard, PhD The institution of Dr. Howard has received research support from NIH. The institution of an immediate family member of Dr. Howard has received research support from NIH.
George Howard, PhD Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer.
Nirupama Yechoor, MD Dr. Yechoor has nothing to disclose.
Cornelia Van Duijn No disclosure on file
Thomas Littlejohns No disclosure on file
Jonathan Rosand, MD Dr. Rosand has received personal compensation for serving as an employee of Massachusetts General Hospital. Dr. Rosand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Rosand has received research support from NIH. The institution of Dr. Rosand has received research support from American Heart Association. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as a Peer reviewer with National Institutes of Health. Dr. Rosand has a non-compensated relationship as a Trustee with Columbia University that is relevant to AAN interests or activities.
Gregory Fricchione No disclosure on file
Christopher D. Anderson, MD, PhD, FAAN The institution of Dr. Anderson has received research support from Bayer AG. The institution of Dr. Anderson has received research support from American Heart Association. The institution of Dr. Anderson has received research support from National Institutes of Health. An immediate family member of Dr. Anderson has received publishing royalties from a publication relating to health care.
Guido J. Falcone, MD The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA.
Megan Conroy No disclosure on file
Naga Vijaya Lakshmi Boorle No disclosure on file
Nithin C. Kurra, MBBS, MPH Dr. Kurra has nothing to disclose.
Nikhila Gandrakota No disclosure on file
Karnav Modi No disclosure on file
Kavya Sudireddy, MBBS Dr. Sudireddy has nothing to disclose.
Shayan Irfan No disclosure on file
Akhil Jain, MD Akhil Jain has nothing to disclose.
Priyanka Parikh No disclosure on file
Dinesh V. Jillella, MD Dr. Jillella has nothing to disclose.
Morris Freedman, MD, FAAN No disclosure on file
Toka S. Elboraay Ms. Elboraay has nothing to disclose.
Hadeer Elsaeed AboElfarh, MD Dr. AboElfarh has nothing to disclose.
Mohamed Elmallahy No disclosure on file
Lena Mansour No disclosure on file
Heba Aboeldahab Heba Aboeldahab has nothing to disclose.
Ahmed Abd Eltawab No disclosure on file
Rehab Diab Rehab Diab has nothing to disclose.
Mahmoud Ebada No disclosure on file
Shrouk F. Mohamed Dr. Mohamed has nothing to disclose.
Mohammed Ilyas, MD Dr. Ilyas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zogenix Professional Advisory Board.
Eric Dunn No disclosure on file
Aarushi Suneja, MD Dr. Suneja has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Suneja has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Mitchel Williams, MD No disclosure on file
Ashhar Ali, DO, FAAN Dr. Ali has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Ali has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Ebsco.
Ahmed A. Mohamedelkhair, MBBS Dr. Mohamedelkhair has nothing to disclose.
Abdelrahman E. Elfaham, MBBS Dr. Elfaham has nothing to disclose.
Katherine Dorfman Ms. Dorfman has nothing to disclose.
Sara Zeccardi, NP Ms. Zeccardi has nothing to disclose.
Seniha N. Ozudogru, MD Dr. Ozudogru has nothing to disclose.
Isaac Smith, DO, MS Dr. Smith has nothing to disclose.
Raissa Aoun, MD Dr. Aoun has nothing to disclose.
Rebecca Lalchan, DO Dr. Lalchan has nothing to disclose.
Jose F. Ortega Tola, MD Dr. Ortega Tola has nothing to disclose.
Daniel Moreno-Zambrano, MD Dr. Moreno-Zambrano has nothing to disclose.
Farah Chohan No disclosure on file
Hector Lalama, MD Dr. Lalama has nothing to disclose.
Mohan C. Deochand, MD Dr. Deochand has nothing to disclose.
Co D. Duong, MD Dr. Duong has nothing to disclose.
John K. Jenkins, MD Dr. Jenkins has nothing to disclose.
Danielle Wilhour, MD Dr. Wilhour has nothing to disclose.
Daniel Kramer No disclosure on file
Cristina A. Cruz, MD Dr. Cruz has nothing to disclose.
Dayna Rivera No disclosure on file
Yadira Flores-Montanez, MD Dr. Flores-Montanez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Flores-Montanez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Rafael J. Lopez-Baquero, MD Dr. Lopez-Baquero has nothing to disclose.
Justin Nofar, MD Dr. Nofar has nothing to disclose.
Mina Sitto Miss Sitto has nothing to disclose.
Yamin Sallowm, MD Dr. Sallowm has nothing to disclose.
Sai Lavanya Patnala, MBBS Ms. Patnala has nothing to disclose.
Anu Mohandas No disclosure on file
Dvir Dori, MD No disclosure on file
Andres Inzunza, MD Dr. Inzunza has nothing to disclose.
Victor Garcia Navarro No disclosure on file
Gabriela Petersen, MD Dr. Petersen has nothing to disclose.
Alexandra Diaz Alba Alexandra Diaz Alba has nothing to disclose.
Daniela Nieto No disclosure on file
Karla Madrigal No disclosure on file
Anabell Ascencio No disclosure on file
Eduardo Martin-Nares No disclosure on file
Edna Amaya No disclosure on file
Jorge Paz Gutierrez No disclosure on file
Manuel Solano No disclosure on file
Cindy Joseph, MD No disclosure on file
Bahadar S. Srichawla, DO, MS Dr. Srichawla has nothing to disclose.
Muhammad Romail Manan No disclosure on file
Vincent Kipkorir Vincent Kipkorir has nothing to disclose.
ARKADEEP DHALI, MBBS Dr. DHALI has nothing to disclose.
Tirtha Sawant Ms. Sawant has nothing to disclose.
Subtain Zia No disclosure on file
Diego Carrion-Alvarez No disclosure on file
Richard Suteja No disclosure on file
Khulud Nurani No disclosure on file
Mihnea Gaman Mihnea Gaman has nothing to disclose.
Sebastian Diebel No disclosure on file
Jacob S. Elkins, MD No disclosure on file
Jeffrey Chen, MD Dr. Chen has nothing to disclose.
Charanpreet Padam, MD, MBBS Charanpreet Padam has nothing to disclose.
Justine E. Cormier, MD Dr. Cormier has nothing to disclose.
Vladislav Zayas, MD Dr. Zayas has nothing to disclose.
Paul Anthony No disclosure on file
Eva Havrdova, MD Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Amanda Rubin, DO Dr. Rubin has nothing to disclose.
Edward J. Gettings, DO Dr. Gettings has nothing to disclose.
Arianna Giebink, MD Dr. Giebink has nothing to disclose.
Paul Partyka, DO, PhD Dr. Partyka has nothing to disclose.
Rajesh Burela, DO Dr. Burela has nothing to disclose.
Hope Okpokam, MD Dr. Okpokam has nothing to disclose.
Daniel E. Kaufman Mr. Kaufman has nothing to disclose.
Sumera Javed No disclosure on file
Yakov Isakov, DO Dr. Isakov has nothing to disclose.
Alexandr L. Safarov, MD Dr. Safarov has nothing to disclose.
Paul Wright, MD, FAAN Dr. Wright has nothing to disclose.
Katherine A. Riester, MPH No disclosure on file
DaYoung Kim, DO Dr. Kim has nothing to disclose.
Xu Tang, DO Dr. Tang has nothing to disclose.
Ian Rankine, DO Dr. Rankine has nothing to disclose.
Amanda Brodeur, DO Dr. Brodeur has nothing to disclose.
Frank Wang, DO Dr. Wang has nothing to disclose.
Sarah Shortall No disclosure on file
Danah Bakir, MD Dr. Bakir has nothing to disclose.
Abdullah Al Sawaf, MD Dr. Al Sawaf has nothing to disclose.
Hayrettin Tumani, MD Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Francesca Pastrana, MD Dr. Pastrana has nothing to disclose.
Hanan Qaqish, MD Dr. Qaqish has nothing to disclose.
Wilson E. Rodriguez, MD Dr. Rodriguez has nothing to disclose.
Adam Awad, MD Dr. Awad has nothing to disclose.
Momina Soudagar-Turkey, MD Dr. Soudagar-Turkey has nothing to disclose.
Subin Jang No disclosure on file
Gavin DeFisser Mr. DeFisser has nothing to disclose.
Tjalf Ziemssen, MD, FAAN Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Margaret M. Wilson-Murphy, MD Dr. Wilson-Murphy has received personal compensation in the range of $0-$499 for serving as a Consultant for DelveBio.
Rebecca MacRae, MD Dr. MacRae has nothing to disclose.
Celia Greenlaw, MD Dr. Greenlaw has nothing to disclose.
Jenifer Moceri, DO Dr. Moceri has nothing to disclose.
Krima Patel, DO Dr. Patel has nothing to disclose.
Cory P. Hackmyer, DO Dr. Hackmyer has nothing to disclose.
Jennifer Axelband, DO Dr. Axelband has nothing to disclose.
Martin Marziniak, PhD No disclosure on file
Sathvik S. Shastry, MD Dr. Shastry has nothing to disclose.
Ajay Menon, MD Dr. Menon has nothing to disclose.
Aiman Sajjad, DO Dr. Sajjad has nothing to disclose.
Cleo Zarina A. Reyes, MD Dr. Reyes has nothing to disclose.
Gary W. Clauser, MD Dr. Clauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bigoen . The institution of Dr. Clauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Clauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech . Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genzyme. Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Novartid.
Omotola A. Hope, MD Dr. Hope has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences.
Donald Gilbert, MD, FAAN Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Illumina. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Emalex Biosciences. The institution of Dr. Gilbert has received research support from NIMH. The institution of Dr. Gilbert has received research support from Emalex Biosciences. The institution of Dr. Gilbert has received research support from PTC Therapeutics. The institution of Dr. Gilbert has received research support from Department of Defense. The institution of Dr. Gilbert has received research support from Quince Therapeutics. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Medical Second Opinion Expert with Teldoc/Advanced Medical. Dr. Gilbert has received personal compensation in the range of $10,000-$49,999 for serving as a Medical Expert with Department of Health and Human Services/Vaccine Injury Compensation Program.
Timothy Cunniff, PharmD Dr. Cunniff has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Cunniff has stock in Harmony Biosciences. Dr. Cunniff has stock in Emalex Biosciences.
Frederick E. Munschauer III, MD, FAAN Dr. Munschauer has received personal compensation for serving as an employee of Emalex Biosciences. Dr. Munschauer has stock in Emalex Biosciences.
George Karkanias, PhD Dr. Karkanias has received personal compensation for serving as an employee of Emalex Biosciences, Inc.
Sarah Atkinson Sarah Atkinson has received personal compensation for serving as an employee of Emalex Biosciences. Sarah Atkinson has received personal compensation for serving as an employee of World Wide Clinical Trials.
Stephen Wanaski, PhD Dr. Wanaski has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Wanaski has or had stock in Paragon Biosciences.Dr. Wanaski has or had stock in Emalex Biosciences.
Nandhagopal Ramachandiran, MBBS, DM, FRCP, FAAN, FANA, FAAN Dr. Ramachandiran has nothing to disclose.
Sarah G. Trulove, MBA Ms. Trulove has nothing to disclose.
Leon S. Dure, MD Dr. Dure has nothing to disclose.
Jan Rowe No disclosure on file
Emily S. Gantz, DO Dr. Gantz has nothing to disclose.
Irene Malaty, MD, FAAN Dr. Malaty has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aevum. The institution of Dr. Malaty has received research support from Abbvie. The institution of Dr. Malaty has received research support from Revance. The institution of Dr. Malaty has received research support from Parkinson Foundation. The institution of Dr. Malaty has received research support from SAGE. The institution of Dr. Malaty has received research support from Emalex. The institution of Dr. Malaty has received research support from Acadia. Dr. Malaty has received publishing royalties from a publication relating to health care. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Speaker & Center of Excellence Director with Parkinson Foundation. Dr. Malaty has a non-compensated relationship as a MAB member & Center of Excellence Directory with Tourette Association of America that is relevant to AAN interests or activities.
Daniel Ibrahim No disclosure on file
Heather Simpson Martin Heather Simpson Martin has received personal compensation for serving as an employee of Tourette Association of America.
Joshua Wong, MD The institution of Dr. Wong has received research support from NIH.
Natalia Szejko, MD, PhD Dr. Szejko has nothing to disclose.
Davide Martino, MD, PhD Dr. Martino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Martino has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merz Pharma Canada Ltd..
Julian Fletcher No disclosure on file
Tamara M. Pringsheim, MD, FAAN The institution of Dr. Pringsheim has received research support from Canadian Institutes of Health Research. The institution of Dr. Pringsheim has received research support from Azrieli Accelerator.
PHILLIP L. PEARL, MD, FAAN Dr. Pearl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care.
Bruria Ben Zeev No disclosure on file
Daniel Curry, MD The institution of Dr. Curry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearpoint Neuro. The institution of Dr. Curry has received research support from PTC Therapeutics. The institution of Dr. Curry has received research support from Neurogene. The institution of Dr. Curry has received research support from Grace Scientific.
Scellig Stone No disclosure on file
Matthew Vestal No disclosure on file
Rafael Sierra, PhD Dr. Sierra has received personal compensation for serving as an employee of PTC Therapeutics Inc. Dr. Sierra has stock in PTC Therapeutics Inc.
Vinay Penematsa Vinay Penematsa has nothing to disclose.
Antonia Wang No disclosure on file
Lee Golden No disclosure on file
Paul Wuh-Liang Hwu Paul Wuh-Liang Hwu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics Inc.. Paul Wuh-Liang Hwu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC therapeutics. The institution of Paul Wuh-Liang Hwu has received research support from PTC therapeutics.
Tanishq Kesani Mr. Kesani has nothing to disclose.
Lakshmi Sai Deepak Reddy Velugoti, MD No disclosure on file
Shreya R. Kethiri, MBBS Ms. Kethiri has nothing to disclose.
Dhanya Gorty, MBBS Dr. Gorty has nothing to disclose.
Raul De La Fuente-Fernandez, MD No disclosure on file
Cintia Margoth Armas-Puente No disclosure on file
Carlos Cosentino, MD, FAAN Dr. Cosentino has nothing to disclose.
YESENIA NUNEZ CORONADO YESENIA NUNEZ CORONADO has nothing to disclose.
Marcela Alvarado Morales No disclosure on file
Gabriela Gushiken No disclosure on file
MIRIAM VELEZ No disclosure on file
Rafael Suarez No disclosure on file
Luis Torres Luis Torres has nothing to disclose.
Danilo Sanchez Coronel Danilo Sanchez Coronel has nothing to disclose.
Hugo Estrada Vegas No disclosure on file
A J. Stoessl, MD, FAAN No disclosure on file
Audrey Hunt, DO Dr. Hunt has nothing to disclose.
Lubna Jafri, MD, MBBS Dr. Jafri has nothing to disclose.
Jessica Tate, MD The institution of Dr. Tate has received research support from Ipsen. The institution of Dr. Tate has received research support from Boston Scientific. The institution of Dr. Tate has received research support from Revance Therapeutics. The institution of Dr. Tate has received research support from CHDI Foundation. The institution of Dr. Tate has received research support from NINDS. The institution of Dr. Tate has received research support from Michael J. Fox Foundation.
Alexander Paciorkowski, MD The institution of Dr. Paciorkowski has received research support from University of Rochester.
Jaclyn Martindale, DO, FAAN Dr. Martindale has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorder Society. The institution of Dr. Martindale has received research support from Tourette Association of America. The institution of Dr. Martindale has received research support from American Board of Neurology and Psychiatry.
Ginny Lane Ginny Lane has nothing to disclose.
Lia Thibodaux No disclosure on file
Leah Chapman Leah Chapman has received research support from NIH and NINDS.
Solene Moulin No disclosure on file
Prabhjot Kaur Miss Kaur has received research support from DST-INSPIRE.
Davinder Singh No disclosure on file
NAKUL BHARDWAJ No disclosure on file
Neena Bedi No disclosure on file
Saroj Arora No disclosure on file
Didier Leys, MD, FAAN The institution of Dr. Leys has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Leys has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley.
Wenzheng Yu, MD Dr. Yu has nothing to disclose.
Aya N. Shnawa, MD Dr. Shnawa has nothing to disclose.
Jeffrey Swarz, MD No disclosure on file
Ambreen Zaidi No disclosure on file
Lester Y. Leung, MD Dr. Leung has received research support from NIH.
Michaela Pernon No disclosure on file
Chloé Laurencin No disclosure on file
Grégoire Lafay No disclosure on file
Arthur Feyt No disclosure on file
Kenza Drareni Kenza Drareni has nothing to disclose.
Clémence Faulcon No disclosure on file
Emilie Guilpain No disclosure on file
Aurelia Poujois Aurelia Poujois has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orphalan. Aurelia Poujois has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Univar.
Shadi Yaghi, MD Dr. Yaghi has nothing to disclose.
Lakshmi Priya Lalitha, MD Dr. Priya Lalitha has nothing to disclose.
Aya M. Haggiagi, MD No disclosure on file
Katherine Longardner, MD Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. An immediate family member of Dr. Longardner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific. An immediate family member of Dr. Longardner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Trisalus. An immediate family member of Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZenica. An immediate family member of Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sirtex. An immediate family member of Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Society of Interventional Oncology. An immediate family member of Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for France Foundation. An immediate family member of Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Varian. Dr. Longardner has received research support from NIH.
Dietrich Haubenberger, MD, FAAN Dr. Haubenberger has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc. Dr. Haubenberger has stock in Neurocrine Biosciences. Dr. Haubenberger has a non-compensated relationship as a Member of the Board with American Society for Experimental Neurotherapeutics that is relevant to AAN interests or activities.
Yasoda Satpathy Ms. Satpathy has nothing to disclose.
Margaret Tugend Ms. Tugend has nothing to disclose.
Christina M. Ulane, MD, PhD Dr. Ulane has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. The institution of Dr. Ulane has received research support from Cabaletta Bio. The institution of Dr. Ulane has received research support from Arcellx. The institution of Dr. Ulane has received research support from Sanofi.
Raymond Sekula Raymond Sekula has nothing to disclose.
Kevin Patel No disclosure on file
Danielle A. Reynolds, MD Dr. Reynolds has nothing to disclose.
Matthew Stults-Kolehmainen No disclosure on file
Brian Koo, MD Dr. Koo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Regent. Dr. Koo has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Speckhals Law. The institution of Dr. Koo has received research support from Department of Defense.
Paul McKee No disclosure on file
Amanda Divin No disclosure on file
Sanaz Nosrat No disclosure on file
Susannah Williamson No disclosure on file
John Krantz No disclosure on file
Regina Casper No disclosure on file
Miguel Blacutt No disclosure on file
Fabio Amador Bueno No disclosure on file
Riley Avila No disclosure on file
Sachin Agarwal, MD, MPH Dr. Agarwal has nothing to disclose.
Mohamed Ibrahim A. Aleem, MD, FAAN Dr. Aleem has nothing to disclose.
Rajani Sebastian, PhD No disclosure on file
Chintha V. Sriram, MD, MBBS Dr. Sriram has nothing to disclose.
Atanu Biswas, MD Dr. Biswas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for INTAS Pharmaceuticals. Dr. Biswas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for lupin Limited. Dr. Biswas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alkem Laboratories. Dr. Biswas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Torrent Pharmaceuticals.
Arijit Roy Arijit Roy has nothing to disclose.
Adreesh Mukherjee, MD Dr. Mukherjee has nothing to disclose.
Cameron Davis, MS No disclosure on file
Anooshah E. Ata, MD Dr. Ata has nothing to disclose.
Theresa A. Zesiewicz, MD Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lexeo. Dr. Zesiewicz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Steminent. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Malgorzata Jaremko, PhD No disclosure on file
Patrick Vermersch Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Stephane Saubadu, MD Dr. Saubadu has received personal compensation for serving as an employee of Sanofi. Dr. Saubadu has stock in Sanofi.
Philippe Truffinet, MD Dr. Truffinet has received personal compensation for serving as an employee of Sanofi.
Benoit Arnould No disclosure on file
Natalia Hawken No disclosure on file
Charles Minor No disclosure on file
Lita Araujo, PhD Dr. Araujo has received personal compensation for serving as an employee of Sanofi Genzyme.
Samuel Gourlain No disclosure on file
Jérôme Msihid No disclosure on file
Brian Sansoucy No disclosure on file
Shuvro Roy, MD Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Roy has received research support from The Siegel Rare Neuroimmune Association.
Scott D. Newsome, DO, FAAN Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from Lundbeck. The institution of Dr. Newsome has received research support from Sanofi. The institution of Dr. Newsome has received research support from Kyverna Therapeutics. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.
Janel Haughton Janel Haughton has nothing to disclose.
Sat Dev Batish, PhD, FAAN Dr. Batish has received stock or an ownership interest from Quest Diagnostics.
Lawrence P. Goldstick, MD Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for biogen. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for genentech. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for sanofi Aventis genzyme. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for emd serono. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TGA therapeutics. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for emd serono. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Aventis genzyme. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genentech. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyers Squibb. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TGA therapeutics. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for biogen. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for bristol meyers squibb. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for genentech. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for sanofi aventis genzyme. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for emd serono. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TGA therapeutics. The institution of Dr. Goldstick has received research support from biogen. The institution of Dr. Goldstick has received research support from lily. The institution of Dr. Goldstick has received research support from sanofi Aventis genzyme. The institution of Dr. Goldstick has received research support from genetech.
Ben Townsend No disclosure on file
Dusanka Zecevic Dusanka Zecevic has nothing to disclose.
Aisha Augustin No disclosure on file
Catarina Figueiredo Catarina Figueiredo has nothing to disclose.
Susanne Clinch Susanne Clinch has stock in F. Hoffmann-La Roche.
Caroline Giacobino Caroline Giacobino has received personal compensation for serving as an employee of F. Hoffmann-La Roche AG. Caroline Giacobino has stock in F. Hoffmann-La Roche AG.
Oscar Bortolami No disclosure on file
Yun-An Shen Yun-An Shen has received personal compensation for serving as an employee of Genentech Inc. Yun-An Shen has stock in Roche.
Heidemarie Kletzl Heidemarie Kletzl has received personal compensation for serving as an employee of Hoffmann-La Roche.
Robert A. Bermel, MD, FAAN Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
Christopher C. LaGanke, MD Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for GSK. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Serono EMD. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics.
Ryan Shannon, NP Mr. Shannon has received personal compensation for serving as an employee of EMD Serono. Mr. Shannon has received personal compensation for serving as an employee of Biogen Idec. Mr. Shannon has received personal compensation for serving as an employee of TG Therapeutics. Mr. Shannon has received personal compensation for serving as an employee of EMD Serono. Mr. Shannon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Mr. Shannon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Mr. Shannon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Mr. Shannon has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Mr. Shannon has a non-compensated relationship as a Consultant with EMD Serono that is relevant to AAN interests or activities.
Jim Browen Jim Browen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Zhenyuan Wang, PhD Dr. Wang has nothing to disclose.
Lana Zhovtis Ryerson, MD, FAAN Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
John F. Foley, MD, FAAN The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Foley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Foley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Foley has stock in InterPRO Bioscience. The institution of Dr. Foley has received research support from Biogen. The institution of Dr. Foley has received research support from Novartis. The institution of Dr. Foley has received research support from Octave. The institution of Dr. Foley has received research support from Genentech. The institution of Dr. Foley has received research support from Imstem. The institution of Dr. Foley has received research support from Aegir.
Ilya Kister, MD, FAAN Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Gary R. Cutter, PhD Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Ryan Metzger, PhD An immediate family member of Dr. Metzger has received personal compensation for serving as an employee of Neurocrine Biosciences. Dr. Metzger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Interpro Bioscience. An immediate family member of Dr. Metzger has stock in Ascendis. An immediate family member of Dr. Metzger has stock in Neurocrine Biosciences.
Judith Goldberg No disclosure on file
Xiaochun Li No disclosure on file
Evan Riddle, PhD Dr. Riddle has received personal compensation for serving as an employee of Biogen. Dr. Riddle has received stock or an ownership interest from Biogen.
Karen Smirnakis No disclosure on file
Rose M. Domingo-Horne, MD Dr. Domingo-Horne has received personal compensation for serving as an employee of Biogen. Dr. Domingo-Horne has stock in Biogen.
Susie Sinks No disclosure on file
Tyler Lasky Tyler Lasky has received personal compensation for serving as an employee of Biogen. Tyler Lasky has stock in Biogen.
Enrique Alvarez, MD, PhD Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Brandon Brown No disclosure on file
Elizabeth Camacho No disclosure on file
Roland G. Henry, PhD Dr. Henry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MEDDAY. Dr. Henry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Henry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Henry has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi/Genzyme.
Rebecca Piccolo, PhD Dr. Piccolo has received personal compensation for serving as an employee of Novartis. Dr. Piccolo has stock in Novartis.
Le Hua, MD, FAAN Dr. Hua has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Hua has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Hua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Hua has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Hua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Hua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Hua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience. Dr. Hua has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hua has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapuetics. The institution of Dr. Hua has received research support from Genentech.
Kaylan Burnham No disclosure on file
Thomas A. Berger, MD Prof. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a speaker at scientific meetings and participant of local and international advisory boards with various companies producing and markerting treatments for multiple sclerosis (Almirall, Biogen, Biologix, Bionorica, Celgene-BMS, Merck, Novartis, Roche, Sanofi-Genzyme, TG Therapeutics, UCB).
William M. Carroll, MD, MBBS, FRACP, FAAN Dr. Carroll has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Mark S. Freedman, MD, FAAN Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion(Janssen/J&J). Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BiogenIdec. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Inc. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion (Janssen/J&J). Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Healthcare. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BiogenIdec. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRI Bio. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Magenta Therapeutics. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Freedman has received research support from Sanofi Genzyme.
Trygve Holmoy, MD Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Norwegian MS Society. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Rana Karabudak, MD Dr. Karabudak has nothing to disclose.
Joep Killestein Joep Killestein has nothing to disclose.
Carlos Nos, MD Dr. Nos has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffmann-La Roche Ltd..
Ludo J. Vanopdenbosch, MD, FAAN Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for celgene. Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F Hoffmann La Roche. Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme.
Thomas Kuenzel No disclosure on file
Karen Kadner No disclosure on file
Inessa Kulyk Inessa Kulyk has received personal compensation for serving as an employee of Roche. Inessa Kulyk has stock in Roche.
Hans-Peter Hartung, MD, FAAN Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Bruno Brochet, MD, FEAN Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for celgene. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for jansen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for celgene.
Timothy L. Vollmer, MD, FAAN The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Joseph J. Higgins, MD, FAAN No disclosure on file
Francesca Ammoscato No disclosure on file
Justyna Skonieczna No disclosure on file
Jonathan Bestwick No disclosure on file
David Holden No disclosure on file
Mohammad Aboulwafa No disclosure on file
Michael Andrews No disclosure on file
Benjamin Turner Benjamin Turner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono.
Monica Marta Monica Calado-Marta has nothing to disclose.
Klaus Schmierer, MD, PhD Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AXDEV. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MedScape. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroDiem. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Academy. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for F. Hoffmann-La Roche AG. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva.
David Baker No disclosure on file
Sharmilee Gnanapavan, MB Dr. Gnanapavan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Gnanapavan has received research support from NIHR.
Jennifer Vannest No disclosure on file
Dania Mallick, MBBS Dr. Mallick has nothing to disclose.
Nicholas Lannen, MD Dr. Lannen has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genentech. Dr. Lannen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for TG Therapeutics. Dr. Lannen has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Horizon Theraputics.
Catherine Tauro, DO Dr. Tauro has nothing to disclose.
Asaff Harel, MD Dr. Harel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Harel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Harel has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Expert Institute.
Benjamin Kay, MD No disclosure on file
Yan Xu No disclosure on file
Denison Kuruvilla No disclosure on file
John Ratchford, MD Dr. Ratchford has received personal compensation for serving as an employee of Genentech. Dr. Ratchford has stock in F. Hoffman La-Roche.
Qi Qi Qi Qi has nothing to disclose.
Lin Pan No disclosure on file
Jiajie Yu No disclosure on file
Krzysztof W. Selmaj Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Giancarlo Comi, MD Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Jennifer L. Reardon Jennifer L. Reardon has received personal compensation for serving as an employee of Bristol Myers Squibb.
Andrew Thorpe No disclosure on file
Jon Riolo, PhD Dr. Riolo has received personal compensation for serving as an employee of Bristol Myers Squib.
Chun-Yen Cheng Chun-Yen Cheng has received personal compensation for serving as an employee of Bristol Myers Squibb. Chun-Yen Cheng has stock in Bristol Myers Squibb.
James K. Sheffield, MD Dr. Sheffield has received personal compensation for serving as an employee of BMS.
Anthony Krakovich No disclosure on file
Jane B. Allendorfer, PhD The institution of Dr. Allendorfer has received research support from National Institutes of Health. The institution of Dr. Allendorfer has received research support from Evelyn F. McKnight Brain Institute. The institution of Dr. Allendorfer has received research support from LivaNova, Inc. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Cleveland Clinic. Dr. Allendorfer has received personal compensation in the range of $0-$499 for serving as a Examiner with University of Auckland. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International League Against Epilepsy. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Department of Defense. Dr. Allendorfer has a non-compensated relationship as a Scientific Program Committee Member with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Allendorfer has a non-compensated relationship as a Editorial Board Member with Epilepsy and Behavior Reports that is relevant to AAN interests or activities.
Lawrence Steinman, MD, FAAN Dr. Steinman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for 180 Life Sciences. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for BioAtla. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Pasithea. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atreca. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Wilmer Hale Cutler Pickering. Dr. Steinman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Steinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Steinman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for National Academy of Sciences. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Gibson Dunn. The institution of Dr. Steinman has received research support from Roche. The institution of Dr. Steinman has received research support from Novartis. Dr. Steinman has received intellectual property interests from a discovery or technology relating to health care.
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Sarah Harris Sarah Harris has received personal compensation for serving as an employee of BMS. Sarah Harris has stock in BMS.
Robert T. Naismith, MD, FAAN Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squib. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Naismith has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genzyme. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celltrion. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impaact-Bio. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch.
Robert Zivadinov, MD, PhD, FAAN The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Sarah A. Morrow, MD, MSC, FRCPC, FAAN Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono/Merck. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SanofiGenzyme. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Morrow has received research support from Celgene. The institution of Dr. Morrow has received research support from SanofiGenzyme. The institution of Dr. Morrow has received research support from Novartis.
Ann D. Bass, MD Dr. Bass has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion, Amgen, Bristol-Myers-Squibb, EMD Serono, Novartis, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics. Dr. Bass has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen, Alexion, EMD Serono, Novartis, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics. Dr. Bass has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Alexion, Amgen, Bristol-Myers-Squibb, EMD Serono, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics. The institution of Dr. Bass has received research support from Bristol-Myers-Squibb, EMD Serono, Novartis, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics.
Ahmed Z. Obeidat, MD, PhD Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genentech. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for EMD Serono. Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon pharmaceuticals . Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sandoz. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for EMD Serono. Dr. Obeidat has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner life sciences . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/genzyme. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Horizon therapeutics . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. The institution of Dr. Obeidat has received research support from NIH. The institution of Dr. Obeidat has received research support from NMSS and PCORI. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Expert opinion and key opinion leader with MJH life sciences . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Faculty Speaker with CMSC. Dr. Obeidat has a non-compensated relationship as a Board member with CMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Editorial Board Member with IJMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Reviewer Editor with Frontiers Neurology that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Board of Trustee Member with National MS Society that is relevant to AAN interests or activities.
Emily S. Riser, MD Dr. Riser has nothing to disclose.
Sibyl E. Wray, MD Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb/Celgene. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche/Genentech. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/Genzyme. The institution of Dr. Wray has received research support from Biogen. The institution of Dr. Wray has received research support from Atara Biotherapeutics. The institution of Dr. Wray has received research support from Bristol Myers Squibb/Celgene. The institution of Dr. Wray has received research support from Novartis. The institution of Dr. Wray has received research support from Roche/Genentech. The institution of Dr. Wray has received research support from Sanofi/Genzyme. The institution of Dr. Wray has received research support from TG Therapeutics. The institution of Dr. Wray has received research support from EMD Serono. The institution of Dr. Wray has received research support from Pharmaceuticals Corp..
Massimiliano Cristofanilli, PhD No disclosure on file
Burhan Z. Chaudhry, MD Dr. Chaudhry has received personal compensation for serving as an employee of Bristol Myers Squibb.
Kamran Mohiuddin No disclosure on file
John DeLuca, PhD, ABPP Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. DeLuca has received research support from Biogen.
Jerzy P. Szaflarski, MD, PhD, FAAN Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
Timothy Spelman No disclosure on file
Jan Harald Aarseth No disclosure on file
Elisabeth G. Celius, MD Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Celius has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Stig Wergeland, MD, PhD Dr. Wergeland has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wergeland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wergeland has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Wergeland has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Wergeland has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Wergeland has received research support from Biogen.
Melinda Magyari, MD Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Magyari has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Magyari has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. The institution of Dr. Magyari has received research support from The Danish MS Society. The institution of Dr. Magyari has received research support from Biogen. The institution of Dr. Magyari has received research support from Novartis. The institution of Dr. Magyari has received research support from Roche. The institution of Dr. Magyari has received research support from Merck. The institution of Dr. Magyari has received research support from Sanofi.
Elisabeth Framke No disclosure on file
Namita Tundia, PhD Mrs. Tundia has received personal compensation for serving as an employee of EMD Serono.
Schiffon Wong Schiffon Wong has received personal compensation for serving as an employee of EMD Serono.
Jan A. Hillert, MD Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Hillert has received research support from Biogen. The institution of Dr. Hillert has received research support from Celgene. The institution of Dr. Hillert has received research support from Merck. The institution of Dr. Hillert has received research support from Novartis. The institution of Dr. Hillert has received research support from Sanofi. The institution of Dr. Hillert has received research support from Roche.
Yoshie Umemura, MD, FAAN Dr. Umemura has received personal compensation for serving as an employee of Barrow Neurological Institute. Dr. Umemura has received personal compensation for serving as an employee of University of Michigan. Dr. Umemura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Qessential. Dr. Umemura has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Servier. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Honorarium with Curio Science LLC. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Honorarium with OncLive. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Honorarium with MJH Life Sciences.
Galina Vorobeychik, MD, FRCPC, FAAN Dr. Vorobeychik has nothing to disclose.
Himali Bergeron-Vitez Miss Bergeron-Vitez has nothing to disclose.
Jill Nelson No disclosure on file
Anna Kazimirchik No disclosure on file
Bade Gulec Bade Gulec has nothing to disclose.
Elif Everest, PhD Ms. Everest has received personal compensation in the range of $50,000-$99,999 for serving as a postdoctoral visiting fellow with National Institutes of Health.
Melih Tutuncu, MD Dr. Tutuncu has nothing to disclose.
Sabahattin Saip Sabahattin Saip has nothing to disclose.
Aksel Siva, MD Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
Ugur Uygunoglu Ugur Uygunoglu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Turkey . The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec/Gen Pharma of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck-Serono of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanovel of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genveon of Turkey.
Ogeday Gorkey No disclosure on file
Metehan Koc No disclosure on file
Thomas Doerner No disclosure on file
Warner Carr Warner Carr has nothing to disclose.
Koremasa Hayama No disclosure on file
Michihiro Hide No disclosure on file
Marcus Maurer No disclosure on file
Xavier Montalban, MD, PhD, FAAN The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Gordon Sussman No disclosure on file
Heinz Wiendl, MD, FAAN Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Swapnil Dahale No disclosure on file
Virginia DeLasHeras Virginia DeLasHeras has received personal compensation for serving as an employee of NOVARTIS.
Sibylle Haemmerle No disclosure on file
Bernd C. Kieseier, MD Dr. Kieseier has received personal compensation for serving as an employee of Novartis. Dr. Kieseier has stock in Novartis.
Karine Lheritier No disclosure on file
Artem Zharkov No disclosure on file
Roman Willi, PhD Dr. Willi has received personal compensation for serving as an employee of Novartis Pharma. Dr. Willi has received stock or an ownership interest from Novartis.
Ana Gimenez-Arnau No disclosure on file
Pamela Rist, PhD The institution of Dr. Rist has received research support from National Institutes of Health. The institution of Dr. Rist has received research support from Brigham and Women's Hospital. The institution of Dr. Rist has received research support from American Heart Association. The institution of Dr. Rist has received research support from Mars Edge.
Samantha Mora Samantha Mora has nothing to disclose.
Taylor McVeigh Taylor McVeigh has nothing to disclose.
Cesar E. Escamilla-Ocanas, MD Dr. Escamilla-Ocanas has nothing to disclose.
Noelia C. Morales, MD Dr. Morales has nothing to disclose.
Rahul Damani Rahul Damani has nothing to disclose.
Eric Bershad, MD Dr. Bershad has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various.
Mohammad I. Hirzallah, MD Dr. Hirzallah has nothing to disclose.
Khawja A. Siddiqui, MD Dr. Siddiqui has nothing to disclose.
Chethan P. Venkatasubba Rao, MD Dr. Venkatasubba Rao has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Maestro Inc.
Muhammad S. Zafar, MBBS Dr. Zafar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharmaceuticals. Dr. Zafar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova . The institution of Dr. Zafar has received research support from UCB. The institution of Dr. Zafar has received research support from SK life. The institution of Dr. Zafar has received research support from Marinus. The institution of Dr. Zafar has received research support from LivaNova. The institution of Dr. Zafar has received research support from Biopharma. The institution of Dr. Zafar has received research support from Neurocrine. The institution of Dr. Zafar has received research support from Hartwell Foundation.
Atul Phillips No disclosure on file
Jeyaraj D. Pandian, MD, DM Dr. Pandian has nothing to disclose.
Maximiliano A. Hawkes, MD Dr. Hawkes has or had stock in Navinetics-AI.
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Adam De Havenon, MD, FAAN Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Alejandra M. Stewart, MD No disclosure on file
Joyeta Razzaque, MBBS Dr. Razzaque has nothing to disclose.
Syed Muhammad Owais Mr. Owais has nothing to disclose.
Hira Pervez, MD, MBBS Dr. Pervez has nothing to disclose.
Vinh N. Pham, MD Dr. Pham has nothing to disclose.
Sahil Sakibuzzaman, MD Dr. Sakibuzzaman has nothing to disclose.
Mohammad M. Samara, MD Dr. Samara has nothing to disclose.
Vicki A. Ramsey-Williams, MD, PhD Dr. Ramsey-Williams has nothing to disclose.
Bashar Saour, MD Dr. Saour has nothing to disclose.
Elysia James, MD Dr. James has nothing to disclose.
Claire Popovich No disclosure on file
Robert J. Baumann, MD, FAAN Dr. Baumann has nothing to disclose.
Chelsea Sykora, MD Ms. Sykora has nothing to disclose.
Cameron Hill Mr. Hill has nothing to disclose.
Charlene J. Ong, MD Dr. Ong has nothing to disclose.
Min Shin Min Shin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Overvak.
Stephen Schmugge Stephen Schmugge has nothing to disclose.
Samuel Tate Samuel Tate has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Overvak. Samuel Tate has received personal compensation in the range of $100,000-$499,999 for serving as a Software Engineer with ECHAS.
Joseph Sisto Joseph Sisto has nothing to disclose.
Michael F. Cronin The institution of Mr. Cronin has received research support from American Heart Association.
Paul W. O'Connor, MD No disclosure on file
Katherine M. Clifford, MD Dr. Clifford has nothing to disclose.
Miriam L. Freimer, MD, FAAN Dr. Freimer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for J and J. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Freimer has received research support from Alnylum. The institution of Dr. Freimer has received research support from UCB. The institution of Dr. Freimer has received research support from NIH. The institution of Dr. Freimer has received research support from Janssen. Dr. Freimer has received research support from Avidity. Dr. Freimer has received research support from Fulcrum. The institution of Dr. Freimer has received research support from Dept of defense. The institution of an immediate family member of Dr. Freimer has received research support from Abcurro. Dr. Freimer has received personal compensation in the range of $10,000-$49,999 for serving as a presentations/teaching with UCB.
Neelam Goyal, MD, FAAN Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Goyal has received research support from Argenx.
Tahseen Mozaffar, MD, FAAN Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas Gene Therapy. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Astellas Gene Therpay. The institution of Dr. Mozaffar has received research support from Cartesian. The institution of Dr. Mozaffar has received research support from Cabaletta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Pushpa Narayanaswami, MD, MBBS, FAAN Dr. Narayanaswami has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for UCB. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx USA. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD pharma. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD-Serono (Merck usa). Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Immuneabs. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viridian. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta-Bio. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vor Bio. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Muscle and Nerve, Wiley. Dr. Narayanaswami has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Narayanaswami has or had stock in Dr. Reddys laboratories.Dr. Narayanaswami has or had stock in Doximity. The institution of Dr. Narayanaswami has received research support from Alexion. The institution of Dr. Narayanaswami has received research support from NIH. The institution of Dr. Narayanaswami has received research support from Argenx. The institution of Dr. Narayanaswami has received research support from Cabaletta Bio. Dr. Narayanaswami has received publishing royalties from a publication relating to health care. Dr. Narayanaswami has a non-compensated relationship as a Member, Finance Committee with AANEM that is relevant to AAN interests or activities.
Srikanth Muppidi, MD, FAAN Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J & J pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care.
Anahit C. Mehrabyan, MD Dr. Mehrabyan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UVB. Dr. Mehrabyan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenex.
Amanda C. Guidon, MD, MPH An immediate family member of Dr. Guidon has received personal compensation for serving as an employee of GE Healthcare. Dr. Guidon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Guidon has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN - Continuum. The institution of Dr. Guidon has received research support from NINDS. Dr. Guidon has received publishing royalties from a publication relating to health care. Dr. Guidon has a non-compensated relationship as a Committee Member with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Guidon has a non-compensated relationship as a Executive Committee Member with Neuromuscular Study Group that is relevant to AAN interests or activities.
Michael K. Hehir II, MD Dr. Hehir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Hehir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Hehir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Hehir has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Hehir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Hehir has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum- 好色先生. Dr. Hehir has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. The institution of Dr. Hehir has received research support from Myasthenia Gravis Foundation of America. The institution of Dr. Hehir has received research support from University of Vermont Medical Center.
Ali A. Habib, MD Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NMD Pharma. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/ Amgen. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jansen/Johnson & Johnson. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMDSerono/Merck. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH/NINDS. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunis Biomedical. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman-La Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jansen/Joohnson & Johnson. The institution of Dr. Habib has received research support from Alexion. The institution of Dr. Habib has received research support from Horizon/Amgen. The institution of Dr. Habib has received research support from Immunovant. The institution of Dr. Habib has received research support from UCB. The institution of Dr. Habib has received research support from argenx. The institution of Dr. Habib has received research support from CabalettaBio. The institution of Dr. Habib has received research support from Regeneron. The institution of Dr. Habib has received research support from Arcellx. The institution of Dr. Habib has received research support from Novartis. The institution of Dr. Habib has received research support from EMDSerono/Merck. The institution of Dr. Habib has received research support from Cour Pharmaceuticals.
Dave S. Ho, MD Dr. Ho has stock in Moderna.
Samantha Blum, DO Dr. Blum has nothing to disclose.
Guido Sabatella Guido Sabatella has received personal compensation for serving as an employee of Alexion.
Andrew J. Gordon, MD Dr. Gordon has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catalyst. Dr. Gordon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Gordon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion . Dr. Gordon has received personal compensation in the range of $0-$499 for serving as a Consultant for Vertex. Dr. Gordon has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Gordon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Gordon has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Gordon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Cassiday.
Michael T. Pulley, MD, PhD, FAAN Dr. Pulley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amylyx. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for csl/behring. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta. Dr. Pulley has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Multiple law firms.
Saida Sharapova No disclosure on file
James F. Howard, Jr., MD, FAAN Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx . Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN (Horizon Therapeutics). Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Ltd. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck EMD Serono. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for H. Lundbeck A/S. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Seismic Therapeutics. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vor Biopharma. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Academic CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PeerView CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Platform Q CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for MJH LifeSci. Dr. Howard has or had stock in Johnson & Johnson dividends.Dr. Howard has or had stock in Pfizer dividends. An immediate family member of Dr. Howard has or had stock in GlaxoSmithKline dividends.Dr. Howard has or had stock in Bristol Myer Squbb dividends.Dr. Howard has or had stock in AbbieVie Inc. The institution of Dr. Howard has received research support from Alexion Pharmaceuticals. The institution of Dr. Howard has received research support from argenx . The institution of Dr. Howard has received research support from UCB Biosciences. The institution of Dr. Howard has received research support from NIH. The institution of Dr. Howard has received research support from Centers for Disease Control/Research Triangle Institute. The institution of Dr. Howard has received research support from Cartestian Therapeutics. The institution of Dr. Howard has received research support from NMD Pharma. The institution of Dr. Howard has received research support from Ad Scientiam. The institution of Dr. Howard has received research support from Merck EMD Serono. Dr. Howard has a non-compensated relationship as a Scientific Advisiory Board member, Committee member with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Howard has a non-compensated relationship as a Committee member with American Assoc Neuromuscular and Electrodiagnostic Medicine that is relevant to AAN interests or activities.
Akshay M. Shah, MD No disclosure on file
Zabeen K. Mahuwala, MD, FAAN Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for academic CME. Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Scientific affairs. Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for amgen. The institution of Dr. Mahuwala has received research support from UCB, . The institution of Dr. Mahuwala has received research support from Alexion . The institution of Dr. Mahuwala has received research support from argenx . The institution of Dr. Mahuwala has received research support from immunovant.
Julian Grosskreutz Dr. Grosskreutz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Grosskreutz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Grosskreutz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Grosskreutz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. The institution of Dr. Grosskreutz has received research support from Boris Canessa Foundation.
Renato Mantegazza, MD Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Mantegazza has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SERB. The institution of Dr. Mantegazza has received research support from Alpine Immune Sciences, Inc.
Robert M. Pascuzzi, MD, FAAN Dr. Pascuzzi has nothing to disclose.
Sabrina Sacconi, MD Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LUPIN. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMICUS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for FULCRUM THERAPEUTICS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for AXELYS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for OLOGY. The institution of Dr. Sacconi has received research support from Solve FSHD.
John Vissing, MD Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Prof. Vissing has received personal compensation in the range of $0-$499 for serving as a Consultant for Denali Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Italfarmaco. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Prof. Vissing has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson & Johnson (Janssen). Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Edgewise Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Prof. Vissing has received research support from Rigshospitalet. The institution of Prof. Vissing has received research support from Avidity. The institution of Prof. Vissing has received research support from Sanofi. The institution of Prof. Vissing has received research support from Roche. The institution of Prof. Vissing has received research support from AnnJi.
Tuan H. Vu, MD Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen (Horizon). Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Vu has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Alexion. The institution of Dr. Vu has received research support from RA Pharma/UCB. The institution of Dr. Vu has received research support from Mass Gen Hospital/Healy Platform Study. The institution of Dr. Vu has received research support from ARGENX. The institution of Dr. Vu has received research support from Horizon/Amgen. The institution of Dr. Vu has received research support from Woolsey Pharma. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Cartesian Therapeutics. The institution of Dr. Vu has received research support from Janssen/Johnson & Johnson. The institution of Dr. Vu has received research support from Immunovant. The institution of Dr. Vu has received research support from Regeneron. The institution of Dr. Vu has received research support from Dianthus. The institution of Dr. Vu has received research support from COUR.
Raphaelle Beau Lejdstrom Raphaelle Beau Lejdstrom has received personal compensation for serving as an employee of UCB Frachim SA.
Bernhard Greve, MD Dr. Greve has received personal compensation for serving as an employee of UCB Biosciences. Dr. Greve has stock in UCB Biosciences.
Fiona Grimson Fiona Grimson has received personal compensation for serving as an employee of UCB Pharma. Fiona Grimson has stock in UCB Pharma.
Thais T. Heras, Sr., MD Dr. Heras has received personal compensation for serving as an employee of UCB Pharma S.A.
Vera Bril, MD Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Nicolaas C. Anderson, DO, FAAN Dr. Anderson has nothing to disclose.
Olivia Tong, MD Dr. Tong has received personal compensation for serving as an employee of Alexion Pharmaceuticals.
Torry Cong No disclosure on file
Alanna McEneny Alanna McEneny has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. Alanna McEneny has stock in AstraZeneca.
Min Yee Min Yee has nothing to disclose.
Kendra Drake, MD, FAAN Dr. Drake has nothing to disclose.
Raghav Govindarajan, MD, FAAN Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Bhupendra O. Khatri, MD, FAAN Dr. Khatri has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alexion. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Khatri has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for ER Squibb (Bristol Myer Squibb). Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizone. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyne. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Khatri has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seronoe. Dr. Khatri has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for E.R. Squibb. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Janssen. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutic. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx US. The institution of Dr. Khatri has received research support from Biogen.
Todd D. Levine, MD Dr. Levine has received personal compensation for serving as an employee of CND life sciences . Dr. Levine has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nufactor. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for PNA. Dr. Levine has or had stock in CND Life Sciences.Dr. Levine has or had stock in Corinthian reference lab.
Babak Boroojerdi, MD Dr. Boroojerdi has received personal compensation for serving as an employee of UCB Biosciences. Dr. Boroojerdi has stock in UCB Biosciences.
Eumorphia DELICHA Eumorphia DELICHA has nothing to disclose.
Brittany Harvey No disclosure on file
Andreea Lavrov Andreea Lavrov has received personal compensation for serving as an employee of UCB Biosciences GmbH. An immediate family member of Andreea Lavrov has received personal compensation for serving as an employee of UCB Biosciences GmbH. Andreea Lavrov has stock in UCB Biosciences GmbH. An immediate family member of Andreea Lavrov has stock in UCB Biosciences GmbH.
Bruce M. Coull, MD Dr. Coull has nothing to disclose.
Jana Podhorna Dr. Podhorna has received personal compensation for serving as an employee of argenx. Dr. Podhorna has stock in argenx.
Charlotte Ward No disclosure on file
Ikjae Lee, MD Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. The institution of Dr. Lee has received research support from NIH. The institution of Dr. Lee has received research support from Spastic Paraplegia Foundation.
Yuebing Li, MD, PhD, FAAN Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex. The institution of Dr. Li has received research support from Argenx.
Tobias Ruck No disclosure on file
Elizabeth Teperov Elizabeth Teperov has nothing to disclose.
Ami Shah No disclosure on file
Jeff Guptill, MD, FAAN Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has or had stock in argenx.
Stela Lefter, MD No disclosure on file
Denis Korobko Denis Korobko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Denis Korobko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Denis Korobko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Denis Korobko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biocad. Denis Korobko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Denis Korobko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Denis Korobko has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for sanofi. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jhonson&Jhonson. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra-Zeneca. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Russia. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Moscow. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra-Zeneca. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biocad. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Generium. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Sophie Steeland Sophie Steeland has received personal compensation for serving as an employee of argenx. Sophie Steeland has stock in argenx.
Benjamin Van Hoorick Dr. Van Hoorick has received personal compensation for serving as an employee of argenx. Dr. Van Hoorick has stock in argenx.
Moana Hodari Moana Hodari has nothing to disclose.
Kimiaki Utsugisawa, MD, PhD Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Utsugisawa has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubisi Tanabe pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Utsugisawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for argenx. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion phama. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Japan Blood Products Organization. Dr. Utsugisawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB.
Francesco Sacca, MD, FAAN Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lexeo. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genpharm. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medpharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Madison Pharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zai Lab. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reata. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neopharm Israel. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson&Johnson. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Sacca has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Astrazeneca. The institution of Dr. Sacca has received research support from AIFA. The institution of Dr. Sacca has received research support from FARA.
Jan L. De Bleecker, MD, PhD, FAAN Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgNX. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. De Bleecker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharmaceuticals. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro.
Lauren B. Elman, MD Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Elman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Edgewise Therapeutics. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apellis Pharamaceuticals. Dr. Elman has received publishing royalties from a publication relating to health care.
Hiroyuki Murai, MD Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chugai Pharmaceutical. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Murai has received research support from Japan Blood Products Organization.
Glenn A. Phillips, PhD Dr. Phillips has received personal compensation for serving as an employee of argenx. Dr. Phillips has stock in argenx.
Cynthia Qi Cynthia Qi has received personal compensation for serving as an employee of argenx.
Deborah Gelinas, MD Dr. Gelinas has received personal compensation for serving as an employee of argenx. Dr. Gelinas has stock in argenx.
Edward Brauer Edward Brauer has received personal compensation for serving as an employee of argenx. Edward Brauer has stock in argenx.
Sihui Zhao No disclosure on file
Nabila Dahodwala, MD, FAAN Dr. Dahodwala has received personal compensation in the range of $0-$499 for serving as a Consultant for Genentech. Dr. Dahodwala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mediflix. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Post and Schell. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for O'Brien & Ryan, LLP. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for MotleyRice. The institution of Dr. Dahodwala has received research support from AbbVie. The institution of Dr. Dahodwala has received research support from Medtronic.
Yessar M. Hussain, MD The institution of Dr. Hussain has received research support from Alnylam Pharma.
Kelly G. Gwathmey, MD Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strongbridge. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Gwathmey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals.
Gregory Sahagian, MD, FAAN Dr. Sahagian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Sahagian has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. The institution of Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Sahagian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sahagian has received intellectual property interests from a discovery or technology relating to health care.
Kristl Claeys, MD, PhD Dr. Claeys has nothing to disclose.
Elena Cortes-Vicente Elena Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Elena Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Elena Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Elena Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Elena Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Elena Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. Elena Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Elena Cortes-Vicente has received research support from UCB Pharma. The institution of Elena Cortes-Vicente has received research support from Instituto de Salud Carlos III (España).
Anne Sumbul No disclosure on file
Rosa H. Jimenez, MD, PhD Dr. Jimenez has nothing to disclose.
Daniela Hristova No disclosure on file
Justin Lee Justin Lee has received personal compensation for serving as an employee of Alexion.
Karen Yee, PhD Dr. Yee has received personal compensation for serving as an employee of Alexion. Dr. Yee has stock in Alexion. Dr. Yee has stock in Takeda.
Michael Blackowicz, PhD Dr. Blackowicz has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Dr. Blackowicz has stock in Alexion Pharmaceuticals.
Ema Rodrigues, Other Dr. Rodrigues has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Dr. Rodrigues has stock in Alexion Pharmaceuticals.
Ashley Yegin Ashley Yegin has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Ashley Yegin has stock in Alexion Pharmaceuticals.
Mohamed Khateb Mohamed Khateb has nothing to disclose.
Shahar Shelly, MD Dr. Shelly has or had stock in Remepy.
David Yarnitsky, MD Dr. Yarnitsky has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International association for the study of pain.
Leo McCluskey, MD No disclosure on file
Charlotte Engebrecht Ms. Engebrecht has nothing to disclose.
Spencer Rosero Spencer Rosero has nothing to disclose.
Shaweta Khosa Ms. Khosa has nothing to disclose.
Jennifer Weinstein Jennifer Weinstein has nothing to disclose.
Jamison Seabury Jamison Seabury has nothing to disclose.
Anika Varma Anika Varma has nothing to disclose.
Christina Shupe Ms. Shupe has nothing to disclose.
Charlotte Irwin Ms. Irwin has nothing to disclose.
Alicia Brocht Alicia Brocht has nothing to disclose.
Olimpia Carbunar, MD The institution of Dr. Carbunar has received research support from National Institute of Arthritis and Musculoskeletal and Skin Diseases. The institution of Dr. Carbunar has received research support from ARGENX/PPD.
Michael G. Benatar, MBChB, DPhil, FAAN Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for Annexon. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for UniQure. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cartesian. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CorEvitas. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Canopy. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alaunos. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Woolsey. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Benatar has received intellectual property interests from a discovery or technology relating to health care.
Chad R. Heatwole, MD, FAAN Dr. Heatwole has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Virginia Commonwealth University. Dr. Heatwole has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Legal Med. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Heatwole has received personal compensation in the range of $0-$499 for serving as a Consultant for Iris. Dr. Heatwole has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Recursion. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Biosciences. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Heatwole has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for New York Central Mutual. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Penn Prop and Gas. The institution of Dr. Heatwole has received research support from Department of Defense. The institution of Dr. Heatwole has received research support from Novartis. The institution of Dr. Heatwole has received research support from MJFF. The institution of Dr. Heatwole has received research support from FARA. The institution of Dr. Heatwole has received research support from NIH. The institution of Dr. Heatwole has received research support from University of Miami. The institution of Dr. Heatwole has received research support from MDA. Dr. Heatwole has received intellectual property interests from a discovery or technology relating to health care.
Nakul Katyal, MD Dr. Katyal has nothing to disclose.
Martavius T. Lovall, MD An immediate family member of Dr. Lovall has received personal compensation for serving as an employee of Sylllable .
Chongbo Zhao Chongbo Zhao has nothing to disclose.
Immaculada Aban No disclosure on file
MARCONDES CAVALCANTE FRANCA No disclosure on file
Jorge Gustavo Jose Jorge Gustavo Jose has received personal compensation for serving as an employee of hospital padilla. Jorge Gustavo Jose has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis, . Jorge Gustavo Jose has received personal compensation in the range of $0-$499 for serving as a Consultant for RAFFO. Jorge Gustavo Jose has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NOVARTIS. Jorge Gustavo Jose has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Jorge Gustavo Jose has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI. Jorge Gustavo Jose has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for MERCK. Jorge Gustavo Jose has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ROCHE. The institution of Jorge Gustavo Jose has received research support from NOVARTIS. Jorge Gustavo Jose has received research support from ROCHE. Jorge Gustavo Jose has received research support from SANOFI.
Gerd Meyer Zu Horste, MD Dr. Meyer Zu Horste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant, Argenx, Johnson&Johnson. Dr. Meyer Zu Horste has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen, Argenx, Sanofi. The institution of Dr. Meyer Zu Horste has received research support from Roche. Dr. Meyer Zu Horste has received intellectual property interests from a discovery or technology relating to health care.
Elzbieta Klimiec Ms. Klimiec has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Medison Pharma.
Dario Raul Tavolini Dario Raul Tavolini has nothing to disclose.
Petranka Krumova No disclosure on file
Sian Lennon-Chrimes No disclosure on file
Jillian Smith Jillian Smith has received personal compensation for serving as an employee of Roche Products Ltd. Jillian Smith has stock in Roche Holdings. Jillian Smith has received intellectual property interests from a discovery or technology relating to health care.
Ivana Vodopivec, MD Dr. Vodopivec has received personal compensation for serving as an employee of Roche. An immediate family member of Dr. Vodopivec has received personal compensation for serving as an employee of Novartis. Dr. Vodopivec has stock in Roche.
Gian-Andrea Thanei No disclosure on file
Gil I. Wolfe, MD, FAAN Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ArgenX. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Wolfe has received research support from UCB/Ra. The institution of Dr. Wolfe has received research support from Immunovant. The institution of Dr. Wolfe has received research support from Roche. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving as a Advisor with FDA Advisory Panel for Cellular, Tissue and Genetic Therapies.
Narayani Wagle No disclosure on file
Preetham Bachina Mr. Bachina has nothing to disclose.
Goknur S. Kocak, MD Dr. Kocak has nothing to disclose.
Andrea M. Corse, MD Dr. Corse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Corse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Corse has received personal compensation in the range of $0-$499 for serving as a grant reviewer with FDA.
Nurten Uzun Adatepe No disclosure on file
Kemar E. Green, DO Dr. Green has nothing to disclose.
Linda Chao No disclosure on file
Shota Miyake No disclosure on file
Kenichi Serizawa No disclosure on file
Shinichi Onishi No disclosure on file
Yoshichika Katsura No disclosure on file
Masayuki Baba No disclosure on file
MITSUE KURASAWA No disclosure on file
Haruna Tomizawa-Shinohara No disclosure on file
Keigo Yorozu No disclosure on file
YOSHIHIRO MATSUMOTO No disclosure on file
Mariko Noguchi-Sasaki No disclosure on file
Helena C. Chui, MD The institution of Dr. Chui has received research support from National Institute on Aging .
Julia Greenberg, MD Dr. Greenberg has a non-compensated relationship as a Editorial Board Member with Neurology Resident and Fellow Section that is relevant to AAN interests or activities.
Kiril Kiprovski, MD Dr. Kiprovski has nothing to disclose.
Sujata P. Thawani, MD Dr. Thawani has nothing to disclose.
Aravind Ganesh, MD Dr. Ganesh has received personal compensation in the range of $0-$499 for serving as a Consultant for Figure 1. Dr. Ganesh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier Canada. Dr. Ganesh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Ganesh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli-Lilly. Dr. Ganesh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Let's Get Proof (Collavidence Inc). Dr. Ganesh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生 (journals Neurology and Neurology: Clinical Practice). Dr. Ganesh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association (journal: Stroke). Dr. Ganesh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers (for Frontiers in Neurology). Dr. Ganesh has or had stock in SnapDx.Dr. Ganesh has or had stock in Collavidence Inc.Dr. Ganesh has or had stock in DataSimpl. The institution of Dr. Ganesh has received research support from Canadian Institutes of Health Research . The institution of Dr. Ganesh has received research support from Alberta Innovates. The institution of Dr. Ganesh has received research support from University of Calgary Centre for Clinical Research. The institution of Dr. Ganesh has received research support from Innovation 4 Health. The institution of Dr. Ganesh has received research support from Government of Canada INOVAIT. The institution of Dr. Ganesh has received research support from Campus Alberta Neuroscience. The institution of Dr. Ganesh has received research support from Alzheimer Society of Canada. The institution of Dr. Ganesh has received research support from Heart and Stroke Foundation of Canada. The institution of Dr. Ganesh has received research support from New Frontiers in Research Fund. The institution of Dr. Ganesh has received research support from Panmure House. The institution of Dr. Ganesh has received research support from Brain Canada. The institution of Dr. Ganesh has received research support from MSI Foundation. The institution of Dr. Ganesh has received research support from France Canada Research Fund. Dr. Ganesh has received intellectual property interests from a discovery or technology relating to health care.
Brianne Bettcher No disclosure on file
Nizar Souayah, MD, FAAN Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Caroline Brethenoux No disclosure on file
Alyssa DeLuca No disclosure on file
Jacqueline Pesa Jacqueline Pesa has received personal compensation for serving as an employee of Johnson and Johnson.
Louis Jackson, PharmD Dr. Jackson has received personal compensation for serving as an employee of Johnson and Johnson.
Patrick Furey No disclosure on file
Rosario Alvarez No disclosure on file
Laura Gonzalez Quijano No disclosure on file
Alex Lorenzo No disclosure on file
Ashley E. Anderson, MD Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/Johnson&Johnson. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen.
Zia U. Choudhry, MD, PhD Dr. Chaudhry has received personal compensation for serving as an employee of Johnson & Johnson. Dr. Chaudhry has received personal compensation for serving as an employee of Takeda Pharmaceuticals.
Joel Kramer, PhD The institution of Dr. Kramer has received research support from tau consortium. Dr. Kramer has received publishing royalties from a publication relating to health care.
Yingkai Li, MD, PhD Dr. Li has nothing to disclose.
Simon Gregory No disclosure on file
Michael Aksu No disclosure on file
Tabitha Karatz No disclosure on file
Vern C. Juel, MD, FAAN Dr. Juel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Juel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. The institution of Dr. Juel has received research support from argenx. The institution of Dr. Juel has received research support from Alexion. The institution of Dr. Juel has received research support from Janssen. The institution of Dr. Juel has received research support from NIH Rare Diseases Network.
Padmaja Sudhakar, MD Dr. Sudhakar has nothing to disclose.
Hailey Mair Miss Mair has nothing to disclose.
Nicholas Demas Mr. Demas has nothing to disclose.
Andrew Riddehough No disclosure on file
Nancy J. Newman, MD, FAAN Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight. Dr. Newman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chiesi. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phelcom. The institution of Dr. Newman has received research support from GenSight. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care.
Patrick Yu-Wai-Man Patrick Yu-Wai-Man has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight Biologics. Patrick Yu-Wai-Man has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chiesi. Patrick Yu-Wai-Man has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke Therapeutics. Patrick Yu-Wai-Man has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PYC Therapeutics.
Valerio Carelli, MD, PhD Dr. Carelli has received personal compensation in the range of $0-$499 for serving as a Consultant for Chiesi Farmaceutici. Dr. Carelli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi Farmaceutici.
Valerie Biousse, MD Dr. Biousse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gensights Biologic. Dr. Biousse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Topcon. Dr. Biousse has received publishing royalties from a publication relating to health care. Dr. Biousse has received publishing royalties from a publication relating to health care.
Catherine Vignal-Clermont Catherine Vignal-Clermont has nothing to disclose.
Francois Montestruc Francois Montestruc has received personal compensation for serving as an employee of eXYSTAT.
Magali Taiel Magali Taiel has received personal compensation for serving as an employee of GenSight Biologics.
Jose-Alain Sahel The institution of Jose-Alain Sahel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Avista. The institution of Jose-Alain Sahel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LightStone Ventures. The institution of Jose-Alain Sahel has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for THE BOARD OF GENSIGHT. The institution of Jose-Alain Sahel has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for THE BOARD OF SPARINGVISION. Jose-Alain Sahel has stock in Prophesee. Jose-Alain Sahel has stock in Tilak Healthcare. Jose-Alain Sahel has stock in Sparing Vision. Jose-Alain Sahel has stock in Avista. Jose-Alain Sahel has stock in Tenpoint. Jose-Alain Sahel has stock in SharpEye. Jose-Alain Sahel has stock in GenSight. Jose-Alain Sahel has received intellectual property interests from a discovery or technology relating to health care.
Wayne Macfadden, MD, PT Dr. Macfadden has received personal compensation for serving as an employee of Jazz pharma. Dr. Macfadden has stock in Jazz pharma.
Eileen Leary, PhD Dr. Leary has received personal compensation for serving as an employee of Centessa Pharmaceuticals. Dr. Leary has received personal compensation for serving as an employee of Axsome Therapeutics. Dr. Leary has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Partners Group. Dr. Leary has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulse Infoframe. Dr. Leary has or had stock in Jazz Pharmaceuticals.Dr. Leary has or had stock in Axsome Therapeutics.Dr. Leary has or had stock in Centessa Pharmaceuticals.
Craig Pfister No disclosure on file
Douglas S. Fuller Mr. Fuller has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Mr. Fuller has stock in Jazz Pharmaceuticals.
Ramakrishna Nirogi, PhD Dr. Nirogi has nothing to disclose.
Pradeep Jayarajan, PhD Pradeep Jayarajan, PhD has received personal compensation for serving as an employee of Suven Life Sciences Ltd. Pradeep Jayarajan, PhD has or had stock in Suven Life Sciences.Pradeep Jayarajan, PhD has received intellectual property interests from a discovery or technology relating to health care.
Vijay Benade Vijay Benade has nothing to disclose.
Vinod Goyal Vinod Goyal has received intellectual property interests from a discovery or technology relating to health care.
Anil Shinde Anil Shinde has received intellectual property interests from a discovery or technology relating to health care.
Jyothsna Ravula Jyothsna Ravula has nothing to disclose.
Satish Jetta Satish Jetta has received intellectual property interests from a discovery or technology relating to health care.
Venkat Jasti Venkat Jasti has stock in Suven Life Sciences Ltd. Venkat Jasti has received intellectual property interests from a discovery or technology relating to health care.
Michael J. Thorpy, MD Dr. Thorpy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Thorpy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avadel. Dr. Thorpy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for alkermes. Dr. Thorpy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Thorpy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for centessa. Dr. Thorpy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Thorpy has received publishing royalties from a publication relating to health care.
Marisa Whalen Marisa Whalen has received personal compensation for serving as an employee of Jazz Pharmaceuticals.
Yves Dauvilliers, MD, PhD Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for idorsia. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for JAZZ. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alkermes. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Centessa. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bioprojet. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Bioscience.
Watcharasarn Rattananan, MD No disclosure on file
Mahmoud T. Hefnawy, MD Dr. Hefnawy has nothing to disclose.
Basma Amer No disclosure on file
Samar Ahmed Amer Samar Ahmed Amer has nothing to disclose.
Yehya Khlidj Yehya Khlidj has nothing to disclose.
Bahaa Elfakharany No disclosure on file
Khaled Moghib, MBBS Dr. Moghib has nothing to disclose.
Adel Mouffokes No disclosure on file
Nishant P. Soni Mr. Soni has nothing to disclose.
Zainab Alazzeh No disclosure on file
Mohamed Elsayed No disclosure on file
Jill Blandford, DO No disclosure on file
Richard K. Bogan, MD Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceutical . Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome . Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Harmony. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Axsome. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Jazz. The institution of Dr. Bogan has received research support from Jazz Pharmaceuticals. The institution of Dr. Bogan has received research support from Harmony . The institution of Dr. Bogan has received research support from Eisai. The institution of Dr. Bogan has received research support from Avadel. The institution of Dr. Bogan has received research support from Takeda. The institution of Dr. Bogan has received research support from Suven. The institution of Dr. Bogan has received research support from Axsome. The institution of Dr. Bogan has received research support from Merck. The institution of Dr. Bogan has received research support from Liva Nova. The institution of Dr. Bogan has received research support from Nyxoah. Dr. Bogan has received research support from Bayer. Dr. Bogan has received intellectual property interests from a discovery or technology relating to health care.
Logan D. Schneider, MD Dr. Schneider has received personal compensation for serving as an employee of Alphabet, Inc. Dr. Schneider has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avadel Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Axsome. Dr. Schneider has received intellectual property interests from a discovery or technology relating to health care.
Cristina Casstevens Cristina Casstevens has received personal compensation for serving as an employee of Jazz Pharmaceuticals . Cristina Casstevens has stock in Jazz Pharmaceuticals.
Gwendolyn C. Claussen, MD No disclosure on file
Thomas Roth, PhD Dr. Roth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Roth has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Avadel. Dr. Roth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz.
Giuseppe Plazzi, MD The institution of Dr. Plazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TAKEDA. The institution of Dr. Plazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOPROJET. The institution of Dr. Plazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for JAZZ. The institution of Dr. Plazzi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for OREXIA. The institution of Dr. Plazzi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for OREXIA/CENTESSA.
Jed Black, MD Jed Black, MD has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Jed Black, MD has stock in Jazz Pharmaceuticals. Jed Black, MD has stock in .
Shin J. Oh, MD, FAAN No disclosure on file
Patrick Z. Liu, PhD Dr. Liu has nothing to disclose.
David M. Raizen, MD Dr. Raizen has nothing to disclose.
Carsten Skarke No disclosure on file
Thomas Brooks No disclosure on file
Ron Anafi No disclosure on file
Mohammad Alsharabati, MD No disclosure on file
Clete A. Kushida, MD, PhD Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avadel. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Kushida has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for XW Pharma, Inc.. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zephyr Sleep Technologies. Dr. Kushida has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vivos. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerebra. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck & Co., Inc.. Dr. Kushida has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for State of Arizona. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Browne George Ross, LLP. The institution of Dr. Kushida has received research support from AmCAD, Philips-Respironics, Asate, Syneos Health, Inspire. Dr. Kushida has received publishing royalties from a publication relating to health care.
Anne Marie Morse No disclosure on file
John Harsh, PhD Dr. Harsh has nothing to disclose.
Luis Ortiz Luis Ortiz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel. Luis Ortiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Luis Ortiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Biosciences. Luis Ortiz has stock in Ascendis Pharma. Luis Ortiz has a non-compensated relationship as a Speaker with Wake Up Narcolepsy that is relevant to AAN interests or activities.
Jennifer Gudeman Miss Gudeman has received personal compensation for serving as an employee of Avadel Pharmaceuticals. Miss Gudeman has stock in Avadel Pharmaceuticals.
Craig Chepke Craig Chepke has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Craig Chepke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka. Craig Chepke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Craig Chepke has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Neurocrine. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Acadia. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Otsuka. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Takeda. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Janssen. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Ironshore. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Craig Chepke has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Craig Chepke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Intracellular. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. Craig Chepke has received research support from Acadia. Craig Chepke has received research support from Harmony. Craig Chepke has received research support from Neurocrine.
Andrew Cutler Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for AbbVie. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Alkermes. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Axsome. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Boehringer Ingelheim. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Bristol Myers Squibb. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Delpor. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for 4M Therapeutics. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Intra-Cellular Therapies. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for J&J. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Jazz Pharma. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Lundbeck. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for MapLight Therapeutics. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Neumora. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Neurocrine. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Noven. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Otsuka. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Relmada. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Supernus. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Teva. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Tris Pharma. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for COMPASS Pathways. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Freedom Biosciences. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for AbbVie. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alkermes. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Axsome. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Intra-Cellular Therapies. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for J&J. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Lundbeck. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Neurocrine. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Noven. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Otsuka. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Supernus. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Teva. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Tris Pharma. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Vanda Pharmaceuticals. Andrew Cutler has stock in 4M Therapeutics. Andrew Cutler has stock in Relmada.
Samantha Floam, DMD Dr. Floam has received personal compensation for serving as an employee of Axsome Therapeutics.
Gregory S. Parks, PhD Dr. Parks has received personal compensation for serving as an employee of Axsome Therapeutics. Dr. Parks has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Parks has stock in Axsome Therapeutics. Dr. Parks has stock in Jazz Pharmaceuticals.
Russell Rosenberg Mr. Rosenberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Mr. Rosenberg has received research support from Neurotrials Research.
QIANG DONG, PhD No disclosure on file
Sophia T. Tong Ms. Tong has nothing to disclose.
Christina Marini Ms. Marini has nothing to disclose.
Azizi Seixas No disclosure on file
Lisa Doan No disclosure on file
Ricardo Osorio No disclosure on file
Duaa Bnayan Duaa Bnayan has nothing to disclose.
Monica Salmeron No disclosure on file
Emrah Aras No disclosure on file
Marcondes C. Franca, Jr., MD Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Franca has received research support from FARA.
Ibrahim Serag, MD Dr. Serag has nothing to disclose.
Amro E. AbuShanab, MBBS Dr. AbuShanab has nothing to disclose.
Ahmed Abbas, MD Dr. Abbas has nothing to disclose.
Zahid Iqbal, MD Dr. Iqbal has nothing to disclose.
Eric Dunn, DO Dr. Dunn has nothing to disclose.
Gerard Harty Gerard Harty has received personal compensation for serving as an employee of Merck KGaA Darmstadt.
Erica Escalera Miss Escalera has nothing to disclose.
Jeffrey L. Saver, MD, FAAN Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical.
Roxanna Nahvi, MD, PhD Dr. Nahvi has nothing to disclose.
Maresa Caunt Mrs. Caunt has received personal compensation for serving as an employee of Genentech. Mrs. Caunt has stock in Genentech.
Rodrigo Sanjinez, Sr., MD Dr. Sanjinez has nothing to disclose.
Raphael Besborodco, MD Dr. Besborodco has nothing to disclose.
Danna Cruz No disclosure on file